Quiver News | Quiver Quantitative

BridgeBio Pharma Presents Long-Term Acoramidis Data Showing Potential Cardiac Reversal and Extended Survival Benefits in ATTR-CM at ESC Congress 2026

33 minutes ago | Aug. 30, 2026 2:10 p.m. UTC

Acoramidis shows potential to reverse cardiac disease progression in ATTR-CM, improving survival and heart function in patients.

Quiver AI Summary

BridgeBio Pharma, Inc. announced significant findings regarding acoramidis, a therapy for transthyretin amyloid cardiomyopathy (ATTR-CM), at the European Society of Cardiology Congress 2026. Acoramidis is the first treatment shown to potentially reverse cardiac structural disease progression as demonstrated through cardiac magnetic resonance imaging (CMR) over a 42-month period. Results indicate that almost 50% of patients experienced clinically meaningful improvements in cardiac function, and those treated with acoramidis had up to 65 additional days alive and out of the hospital compared to placebo patients by the 36-month mark. The treatment demonstrated long-term efficacy and safety across various ATTR-CM subgroups, including the prevalent p.Val142Ile variant. Findings presented also noted substantial improvements in health-related quality of life for patients receiving acoramidis. This innovative therapy is designed to stabilize transthyretin and represents a significant shift towards restoring heart health in patients with ATTR-CM, rather than merely managing disease progression.

Potential Positives

Acoramidis is the first therapy to show potential reversal of cardiac disease progression in patients with ATTR-CM, based on significant improvements observed through 42 months of follow-up.
Clinical data indicates that acoramidis-treated patients experienced an unprecedented 65 additional days alive and out of the hospital by Month 36 compared to those on placebo.
The therapy demonstrated long-term efficacy and safety across different genetic subgroups of ATTR-CM, providing a broader treatment option for patients affected by this condition.
Acoramidis has received regulatory approvals from multiple health authorities, highlighting its credibility and availability for patients with ATTR-CM worldwide.

Potential Negatives

Significant reliance on post-hoc analyses which may not be predictive of future clinical outcomes, raising concerns about the robustness of the findings.
Reported high all-cause mortality rates (30.4% with continuous acoramidis) indicate a substantial unmet medical need, suggesting limitations in the efficacy of the therapy.
Forward-looking statements outline numerous uncertainties regarding the clinical significance and therapeutic implications of the data, exposing potential risks to stakeholders.

FAQ

What is acoramidis used for?

Acoramidis is a transthyretin stabilizer indicated for treating cardiomyopathy in adults with wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM).

How does acoramidis affect cardiac function?

Acoramidis may reverse cardiac structural disease progression, with around 65% of patients showing meaningful improvement in cardiac function over time.

What were the primary findings of the ATTRibute-CM study?

The study showed acoramidis preserves additional days alive outside the hospital and demonstrates long-term efficacy in various ATTR-CM subgroups.

Is acoramidis safe for patients?

Acoramidis was well tolerated in studies, with adverse reactions primarily mild and similar discontinuation rates compared to placebo.

What is next for acoramidis development?

BridgeBio plans to present additional data on acoramidis at future medical meetings, focusing on its sustained effects and potential benefits.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

EARLY ACCESS

Receive BBIO Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$BBIO Insider Trading Activity

$BBIO insiders have traded $BBIO stock on the open market 61 times in the past 6 months. Of those trades, 0 have been purchases and 61 have been sales.

Here’s a breakdown of recent trading of $BBIO stock by insiders over the last 6 months:

NEIL KUMAR (Chief Executive Officer) has made 0 purchases and 44 sales selling 311,083 shares for an estimated $22,422,909.
JENNIFER E. COOK has made 0 purchases and 6 sales selling 278,192 shares for an estimated $21,920,434.
ANDREA ELLIS has made 0 purchases and 2 sales selling 82,088 shares for an estimated $5,653,329.
HANNAH VALANTINE has made 0 purchases and 3 sales selling 13,675 shares for an estimated $965,835.
RANDAL W. SCOTT has made 0 purchases and 4 sales selling 10,000 shares for an estimated $671,455.
MARICEL APULI (Chief Accounting Officer) has made 0 purchases and 2 sales selling 4,000 shares for an estimated $303,280.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$BBIO Congressional Stock Trading

Members of Congress have traded $BBIO stock 5 times in the past 6 months. Of those trades, 5 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $BBIO stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 5 times. They made 5 purchases worth up to $75,000 on 05/11, 04/29, 03/19, 03/18, 03/03 and 0 sales.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$BBIO Hedge Fund Activity

We have seen 259 institutional investors add shares of $BBIO stock to their portfolio, and 258 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

BLACKROCK, INC. removed 3,920,601 shares (-27.6%) from their portfolio in Q2 2026, for an estimated $292,006,362
WELLINGTON MANAGEMENT GROUP LLP added 2,824,971 shares (+113.7%) to their portfolio in Q2 2026, for an estimated $210,403,840
BROOKLANDS FUND MANAGEMENT LTD removed 2,750,000 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $204,215,000
JPMORGAN CHASE & CO added 2,397,995 shares (+inf%) to their portfolio in Q2 2026, for an estimated $178,602,667
PRICE T ROWE ASSOCIATES INC /MD/ removed 2,075,272 shares (-54.6%) from their portfolio in Q2 2026, for an estimated $154,566,258
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. removed 1,900,000 shares (-55.1%) from their portfolio in Q2 2026, for an estimated $141,512,000
VIKING GLOBAL INVESTORS LP removed 1,893,215 shares (-16.0%) from their portfolio in Q2 2026, for an estimated $141,006,653

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$BBIO Analyst Ratings

Wall Street analysts have issued reports on $BBIO in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

William Blair issued a "Outperform" rating on 03/10/2026

To track analyst ratings and price targets for $BBIO, check out Quiver Quantitative's $BBIO forecast page.

$BBIO Price Targets

Multiple analysts have issued price targets for $BBIO recently. We have seen 9 analysts offer price targets for $BBIO in the last 6 months, with a median target of $100.0.

Here are some recent targets:

Salim Syed from Mizuho set a target price of $96.0 on 06/16/2026
Whitney Ijem from Canaccord Genuity set a target price of $104.0 on 06/03/2026
Raghuram Selvaraju from HC Wainwright & Co. set a target price of $110.0 on 05/28/2026
Sean Laaman from Morgan Stanley set a target price of $98.0 on 05/28/2026
Eric Joseph from Citigroup set a target price of $82.0 on 05/19/2026
Cory Kasimov from Evercore ISI Group set a target price of $130.0 on 05/08/2026
Danielle Brill from Truist Securities set a target price of $102.0 on 04/29/2026

Full Release

- Acoramidis is the first therapy shown to potentially reverse cardiac structural disease progression and functional decline through 42 months based on CMR imaging, with up to half of patients showing clinically meaningful improvement in cardiac function in the completer analysis

- Patients treated with acoramidis were observed to have an unprecedented 65 additional days alive and out of the hospital by Month 36 versus baseline placebo patients

- Acoramidis demonstrated long-term efficacy and safety through 54 months across variant ATTR-CM subgroups, including p.Val142Ile and non-p.Val142Ile. These findings were simultaneously published in the European Journal of Heart Failure

PALO ALTO, Calif., Aug. 30, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for genetic conditions, presented new analyses from the Phase 3 ATTRibute-CM study of Attruby ^® (acoramidis) in transthyretin amyloid cardiomyopathy (ATTR-CM), including the cardiac magnetic resonance imaging (CMR) substudy and the open-label extension (OLE) at the European Society of Cardiology (ESC) Congress 2026. Acoramidis is the only selective small molecule, orally administered, near-complete (≥90%) transthyretin (TTR) stabilizer.

“The clinical community is excited about the potential to restore heart health found in these data. For a long time, patients living with ATTR-CM could only hope for a stop to the otherwise relentless progression of disease. These new CMR data from ATTRibute-CM shows evidence of reversal in a meaningful proportion of individuals treated with acoramidis, with roughly half showing improved left ventricular systolic function in the completer analysis, more than 2x the proportion observed in the natural history from a NAC cohort or in ATTRibute-CM participants treated with placebo. These findings support acoramidis as a therapy capable of altering the trajectory of this otherwise progressive disease,” said Marianna Fontana, M.D. of University College London, UK. “For patients and clinicians navigating ATTR-CM, this is an exciting signal that the treatment paradigm is shifting toward a therapy that could actively restore heart health rather than only manage decline.”

The CMR substudy of ATTRibute-CM and its open-label extension provide the first evidence from serial CMR that a therapy can potentially reverse disease progression through Month 42. The findings presented by Awais Sheikh, MBChB of the National Amyloidosis Centre, London, UK were evaluated using two complementary analytical approaches, which found:

In a completer analysis, clinically meaningful improvement from baseline in left ventricular (LV) systolic function was observed in 54% of acoramidis-treated patients versus 20% of placebo-treated patients at Month 30, and in 53% of continuous-acoramidis patients at Month 42
For context, only 26% of completers in an independent natural history cohort demonstrated improved LV systolic function by Month 24 – approximately half the rate observed with acoramidis, suggesting that this magnitude of improvement falls outside the expected natural course of disease
In a conservative analysis, long-term acoramidis treatment was associated with clinically meaningful improvement from baseline in LV systolic function in approximately one-third of patients over 30-42 months. Improvement was observed in 34% of acoramidis-treated patients versus 9% of placebo-treated patients at Month 30 and in 30% of continuous-acoramidis patients at Month 42
In addition, 46% of patients receiving continuous acoramidis demonstrated improvement from baseline in LV mass index at Month 42, providing evidence of favorable structural remodeling
These results provided sufficient evidence for BridgeBio to recently dose its first participant in ASCEND-ATTR, a Phase 3b/4 study designed to determine if acoramidis is associated with sustained improvement in myocardial structural disease progression, function and amyloid burden

In a post-hoc analysis of ATTRibute-CM presented by Richard Wright, M.D. of the Pacific Heart Institute, U.S., acoramidis preserved significantly more time alive outside the hospital for patients with ATTR-CM. The analysis evaluated days lost to death and/or cardiovascular-related hospitalization (DLDCVH), a patient-centered measure that integrates all-cause mortality, cardiovascular-related hospitalizations, and length of stay into a single assessment of disease burden. Key findings included:

In participants with ATTR-CM, acoramidis reduced the estimated mean percentage of DLDCVH to 7.5% versus 11.7% with placebo through Month 30
Acoramidis preserved more than one month of additional time alive and out of the hospital (38 days) over 30 months with the benefit nearly doubling to 65 days (observed) over three years, and nearly tripling to up to 94 days (modelled estimates) over three years, reflecting progressive divergence in outcomes over time

The p.Val142Ile genetic variant is the most common ATTR-CM genetic variant globally, disproportionately affecting individuals of Western African ancestry, with a carrier frequency of 3-4% in the U.S. Black population. Findings in the ATTRibute-CM OLE presented by Kevin Alexander, M.D. of Stanford University School of Medicine, U.S. showed continued benefit of acoramidis in 56 variant ATTR-CM (ATTRv-CM) patients, including 35 p.Val142Ile and 21 non-p.Val142Ile patients through Month 54, demonstrating:

All-cause mortality (ACM) and cardiovascular mortality (CVM) were markedly lower in the continuous acoramidis arm versus placebo-to-acoramidis across both p.Val142Ile and non-p.Val142Ile variant subgroups
Through Month 54, ACM was 30.4% with continuous acoramidis versus 66.7% with placebo-to-acoramidis in the p.Val142Ile subgroup, and 24.3% with continuous acoramidis versus 57.9% with placebo-to-acoramidis across the overall ATTRv-CM population, a consistent, more than two-fold difference in mortality favoring continuous treatment
The ACM and CVM rates at Month 54 were notably high (~65%) in the p.Val142Ile group who were randomized to placebo in ATTRibute-CM, underscoring the substantial unmet medical need in this high-risk subgroup
Continuous acoramidis achieved sustained increases in serum TTR (sTTR) and persistent attenuation of N-terminal pro-B-type natriuretic peptide (NT-proBNP) rise through Month 54 in both participants with p.Val142Ile or non-p.Val142Ile variants
These Month 54 findings extend the survival benefit and favorable biomarker trends previously reported at Month 30, demonstrating the long-term durability of efficacy and safety of acoramidis in ATTRv-CM, including in the p.Val142Ile subgroup
Acoramidis remained well tolerated through Month 54, with no new safety signals observed in the OLE

In addition to the one oral presentation and two moderated posters highlighted, two additional moderated posters on acoramidis were shared at the ESC Congress 2026, including:

Acoramidis Improves Health-Related Quality of Life in Wild-Type and Variant Transthyretin Amyloid Cardiomyopathy: An EQ-5D-5L Subgroup Analysis from ATTRibute-CM , presented by Emer Joyce, M.D., Ph.D. of The Mater Misericordiae University Hospital, IE
- Treatment with acoramidis resulted in significant and clinically meaningful benefits in health-related quality of life (HRQoL) in both wild-type ATTR-CM (ATTRwt-CM) and ATTRv-CM. Greater impact on HRQoL versus placebo was observed in participants with ATTRv-CM
Improvement of Health Status with Acoramidis in Patients with Wild-Type and Variant Transthyretin Amyloid Cardiomyopathy: KCCQ Domains Analysis from the ATTRibute-CM Study, presented by Nitasha Sarswat, M.D. of University of Chicago Medical Center, U.S.
- In ATTRibute-CM, acoramidis attenuated the decline in heart failure-related health status versus placebo in participants with ATTRwt-CM and ATTRv-CM, with consistent benefits observed across Kansas City Cardiomyopathy Questionnaire Overall Summary (KCCQ-OS) and individual domain scores. A numerical improvement was observed across almost all KCCQ domains in acoramidis-treated participants with ATTRwt-CM and ATTRv-CM relative to placebo

As part of BridgeBio's partnership with Yale's Cardiovascular Data Science (CarDS) Lab to advance AI networks for earlier detection of ATTR-CM, three posters were presented at the ESC Congress 2026. Findings from the partnership included:

A Novel AI-Derived Digital Biomarker for Monitoring Disease Progression in ATTR-CM: First-In-Trial Use of a Computer Vision AI-ECG Algorithm within a Phase 3 Pivotal Randomized Controlled Trial, presented by Rohan Khera, M.D. of Yale School of Medicine, U.S.
- This showed the first deployment of a computer vision AI-ECG algorithm, operating directly on ECG data, as a digital biomarker in a RCT (ATTRibute-CM). An image-based AI-ECG algorithm demonstrated discrimination across clinical subgroups at baseline and detected differential longitudinal changes between acoramidis and placebo over 30 months. These findings support the potential role of AI-ECG derived prediction scores as a scalable digital biomarker in clinical trials and potential routine cardiovascular care
A Fully Decentralized, Patient-Led Digital Registry for ATTR-CM Integrating Multisystem EHR and Wearable Data: The DISCOVER-ATTR Study , presented by Aline Pedroso, Ph.D. of Yale School of Medicine
- A fully decentralized, patient-led digital registry can successfully aggregate longitudinal multisystem electronic health records (EHR) data and wearable physiologic signals in ATTR-CM. Early results show substantial data yield and feasibility of longitudinal mapping of care trajectories and multimodal risk prediction, providing a blueprint for next-generation registries in rare cardiovascular diseases
Nationwide U.S. Federated Deployment of Artificial Intelligence for Multimodal Screening of ATTR Cardiomyopathy: First Multicenter Analysis from the TRACE-AI Network , presented by Bruno Batinica, MBChB of Yale School of Medicine
- In this largest-ever deployment of AI-electrocardiogram and AI-Echo models for opportunistic retrospective screening of individuals at risk of ATTR-CM, we demonstrate a large burden of probable undiagnosed ATTR-CM with prognostic implications. Leveraging this framework for screening holds promise for enabling broad, timely identification of patients to maximize the overall benefit of new therapies

Acoramidis is approved as Attruby ^® by the U.S. FDA and is approved as BEYONTTRA ^® by the European Medicines Agency (EMA), Japanese Pharmaceuticals and Medical Devices Agency, Swissmedic, the Swiss Agency for Therapeutic Products, the UK Medicines and Healthcare Products Regulatory Agency, and the Brazilian Health Regulatory Agency ( ANVISA) with all labels specifying near-complete stabilization of TTR.

Additional data on the benefit of Attruby for individuals with ATTR-CM is planned for future medical meetings, including Heart Failure Society of America (HFSA) Annual Scientific Meeting 2026, taking place in Phoenix, Arizona on October 9-12, 2026.

About Attruby ^® (acoramidis)
INDICATION
Attruby is a transthyretin stabilizer indicated for the treatment of the cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM) in adults to reduce cardiovascular death and cardiovascular-related hospitalization.

IMPORTANT SAFETY INFORMATION
Adverse Reactions
Diarrhea (11.6% vs 7.6%) and upper abdominal pain (5.5% vs 1.4%) were reported in patients treated with Attruby versus placebo, respectively. The majority of these adverse reactions were mild and resolved without drug discontinuation. Discontinuation rates due to adverse events were similar between patients treated with Attruby versus placebo (9.3% and 8.5%, respectively).

BridgeBio Forward-Looking Statements
This press release contains forward-looking statements. Statements in this press release may include statements that are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended (the Securities Act), and Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), which are usually identified by the use of words such as “anticipates,” “believes,” “continues,” “estimates,” “expects,” “hopes,” “intends,” “may,” “plans,” “projects,” “remains,” “seeks,” “should,” “will,” and variations of such words or similar expressions. BridgeBio intends these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Exchange Act. These forward-looking statements include statements regarding the potential clinical significance and therapeutic implications of the data presented regarding acoramidis, including the potential clinical and therapeutic implications of observed changes in cardiac structure and function and the potential for acoramidis to alter the trajectory of ATTR-CM and restore heart health; the potential utility of AI-based tools and digital biomarkers for the detection, monitoring and screening of ATTR-CM in clinical trials and clinical practice; and BridgeBio’s plans to present additional data regarding Attruby at future medical meetings. Although the Company believes that its plans, intentions, expectations and strategies as reflected in or suggested by those forward-looking statements are reasonable, the Company can give no assurance that the plans, intentions, expectations or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a number of risks, uncertainties and assumptions, including, but not limited to, initial and ongoing data from the Company’s clinical trials not being indicative of final data, the design and success of ongoing and planned clinical trials, the risk that results from post hoc analyses, subgroup analyses or other analyses may not be predictive of future clinical outcomes or treatment effects, that observed improvements in cardiac structure, function or other measures may not be replicated in additional analyses or studies or translate into improved long-term clinical outcomes, that the potential utility of AI-based tools and digital biomarkers may not be demonstrated in further studies or translate into routine clinical use, that plans to present additional data may change, the impacts of current macroeconomic and geopolitical events, including changing conditions from hostilities in Ukraine and in Israel and the Middle East, increasing rates of inflation and changing interest rates, on business operations and expectations, as well as those risks set forth in the Risk Factors section of the Company’s most recent Quarterly Report on Form 10-Q and Annual Report on Form 10-K and the Company’s other filings with the U.S. Securities and Exchange Commission. Moreover, the Company operates in a very competitive and rapidly changing environment in which new risks emerge from time to time. These forward-looking statements are based upon the current expectations and beliefs of the Company’s management as of the date of this press release, and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Except as required by applicable law, BridgeBio assumes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

About BridgeBio
BridgeBio exists to develop transformative medicines for genetic conditions. Millions of people worldwide living with genetic conditions lack treatment options, often because drug development for small patient populations can be commercially challenging. We aim to bridge the gap between advancements in genetic science and meaningful medicines for underserved patient populations. Our decentralized, hub-and-spoke model is designed for speed, precision, and scalability. Autonomous and empowered teams focus on individual conditions, while a central hub provides the clinical, regulatory, and commercial capabilities needed to bring innovation to market. For more information, visit bridgebio.com and follow us on LinkedIn , X , Facebook , Instagram , YouTube , and TikTok .

BridgeBio Media Contact:
Kaitlyn Reilly, Director, Communications
[email protected]
(650) 789-8220

BridgeBio Investor Contact:
Kristen Kelleher, Director, Investor Relations
[email protected]

Read Full Article

Bloom Energy Stock (BE) Opinions on Data Center Power Demand Surge

39 minutes ago | Aug. 30, 2026 2:03 p.m. UTC

Data Center Demand: Social media chatter highlights Bloom Energy's positioning in the surge of power needs for AI infrastructure. Analysts note the company's unique fuel cell technology aligns with expanding data center projects. Observers point to strong year-to-date performance amid sector tailwinds.

Analyst Views: Recent commentary references reiterated market perform ratings with price targets around recent levels. Discussions emphasize valuation metrics relative to earnings growth from energy sector expansion. Traders share technical setups suggesting continued momentum in coming sessions.

Political Trades: Attention turns to high-profile stock purchases in the name, including leveraged positions tied to policy influences. Participants debate implications for the energy firm's future contracts. Overall tone reflects optimism around sustained interest from institutional flows.

Note: This discussion summary was generated from an AI condensation of post data.

Bloom Energy Insider Trading Activity

Bloom Energy insiders have traded $BE stock on the open market 30 times in the past 6 months. Of those trades, 0 have been purchases and 30 have been sales.

Here’s a breakdown of recent trading of $BE stock by insiders over the last 6 months:

SHAWN MARIE SODERBERG (See Remarks) has made 0 purchases and 11 sales selling 159,653 shares for an estimated $33,467,053.
JOHN T CHAMBERS has made 0 purchases and 3 sales selling 85,000 shares for an estimated $23,206,650.
AMAN JOSHI (Chief Commercial Officer) has made 0 purchases and 6 sales selling 51,335 shares for an estimated $10,499,646.
SATISH CHITOORI (Chief Operations Officer) has made 0 purchases and 6 sales selling 45,965 shares for an estimated $8,938,430.
JEFFREY R IMMELT sold 30,000 shares for an estimated $7,167,300
MACIEJ KURZYMSKI (Chief Accounting Officer) has made 0 purchases and 3 sales selling 16,288 shares for an estimated $3,663,762.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive BE Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

Bloom Energy Revenue

Bloom Energy had revenues of $1.1B in Q2 2026. This is an increase of 174.27% from the same period in the prior year.

You can track BE financials on Quiver Quantitative's BE stock page.

You can access data on BE stock through the Quiver Quantitative API.

Bloom Energy Congressional Stock Trading

Members of Congress have traded $BE stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $BE stock by members of Congress over the last 6 months:

REPRESENTATIVE NANCY PELOSI has traded it 2 times. They made 2 purchases worth up to $6,000,000 on 07/28, 07/24 and 0 sales.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

Bloom Energy Hedge Fund Activity

We have seen 788 institutional investors add shares of Bloom Energy stock to their portfolio, and 520 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JPMORGAN CHASE & CO added 8,085,893 shares (+inf%) to their portfolio in Q2 2026, for an estimated $2,447,599,811
BLACKROCK, INC. removed 6,618,470 shares (-26.4%) from their portfolio in Q2 2026, for an estimated $2,003,410,869
GOLDMAN SACHS GROUP INC added 4,830,139 shares (+53.0%) to their portfolio in Q2 2026, for an estimated $1,462,083,075
AMERIPRISE FINANCIAL INC removed 4,754,452 shares (-20.8%) from their portfolio in Q2 2026, for an estimated $1,439,172,620
D. E. SHAW & CO., INC. removed 4,640,008 shares (-52.7%) from their portfolio in Q2 2026, for an estimated $1,404,530,421
BROOKLANDS FUND MANAGEMENT LTD removed 4,000,000 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $541,960,000
SITUATIONAL AWARENESS LP removed 3,590,614 shares (-35.6%) from their portfolio in Q1 2026, for an estimated $486,492,290

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

Bloom Energy Analyst Ratings

Wall Street analysts have issued reports on $BE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

JP Morgan issued a "Overweight" rating on 04/29/2026
Jefferies issued a "Underperform" rating on 03/27/2026

To track analyst ratings and price targets for Bloom Energy, check out Quiver Quantitative's $BE forecast page.

Bloom Energy Price Targets

Multiple analysts have issued price targets for $BE recently. We have seen 16 analysts offer price targets for $BE in the last 6 months, with a median target of $278.5.

Here are some recent targets:

Ben Kallo from Baird set a target price of $310.0 on 07/09/2026
Julien Dumoulin-Smith from Jefferies set a target price of $246.0 on 07/06/2026
Chip Moore from Roth Capital set a target price of $285.0 on 07/01/2026
Nicholas Amicucci from Evercore ISI Group set a target price of $350.0 on 07/01/2026
Manav Gupta from UBS set a target price of $350.0 on 07/01/2026
Christine Cho from Barclays set a target price of $276.0 on 06/23/2026
Sunaina Ocalan from Bernstein set a target price of $276.0 on 06/17/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

Optimum Communications Stock (OPTU) Opinions on Insider Buying

39 minutes ago | Aug. 30, 2026 2:03 p.m. UTC

Major Insider Acquisition: Social media chatter centers on a significant open-market purchase of Optimum Communications shares by a 10% owner, totaling around $2.5 million across multiple transactions in recent weeks. Observers note the buyer increased their stake substantially at prices between $0.74 and $0.85 per share.

Strategic Context Discussed: Participants highlight the company's ownership in LightPath, a fiber infrastructure provider positioned for AI and cloud connectivity demands, even as recent earnings fell short of expectations. The scale of the commitment has drawn attention as a potential signal amid broader market interest in data center buildouts.

Market Sentiment Building: Discussions emphasize the rarity of such large personal investments by insiders, sparking debate on whether this reflects confidence in upcoming operational improvements. Overall engagement remains focused on monitoring further developments from the filing.

Note: This discussion summary was generated from an AI condensation of post data.

Optimum Communications Insider Trading Activity

Optimum Communications insiders have traded $OPTU stock on the open market 14 times in the past 6 months. Of those trades, 8 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $OPTU stock by insiders over the last 6 months:

NEIL S SUBIN has made 8 purchases buying 3,032,354 shares for an estimated $2,454,821 and 0 sales.
MICHAEL OLSEN (General Counsel and CCRO) has made 0 purchases and 6 sales selling 120,000 shares for an estimated $140,400.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

Optimum Communications Hedge Fund Activity

We have seen 118 institutional investors add shares of Optimum Communications stock to their portfolio, and 103 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

DEUTSCHE BANK AG\ removed 14,738,032 shares (-97.2%) from their portfolio in Q2 2026, for an estimated $21,370,146
KITE LAKE CAPITAL MANAGEMENT (UK) LLP added 11,610,665 shares (+466.4%) to their portfolio in Q2 2026, for an estimated $16,835,464
HUDSON BAY CAPITAL MANAGEMENT LP removed 10,542,481 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $15,286,597
EMPYREAN CAPITAL PARTNERS, LP removed 10,539,395 shares (-42.9%) from their portfolio in Q2 2026, for an estimated $15,282,122
D. E. SHAW & CO., INC. removed 8,977,801 shares (-94.4%) from their portfolio in Q2 2026, for an estimated $13,017,811
JPMORGAN CHASE & CO added 8,893,189 shares (+inf%) to their portfolio in Q2 2026, for an estimated $12,895,124
GOLDMAN SACHS GROUP INC removed 7,824,084 shares (-90.2%) from their portfolio in Q2 2026, for an estimated $11,344,921

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

Optimum Communications Price Targets

Multiple analysts have issued price targets for $OPTU recently. We have seen 3 analysts offer price targets for $OPTU in the last 6 months, with a median target of $1.0.

Here are some recent targets:

Michael Rollins from Citigroup set a target price of $0.5 on 05/15/2026
John Hodulik from UBS set a target price of $1.0 on 05/14/2026
Kannan Venkateshwar from Barclays set a target price of $1.0 on 05/08/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

Amazon Stock (AMZN) Opinions on AI Infrastructure Investments and Market Performance

39 minutes ago | Aug. 30, 2026 2:03 p.m. UTC

Hyperscaler Capex Outlook: Social media chatter highlighted Nvidia's comments on surging capital expenditures at major cloud providers, with projections rising sharply into 2027. Amazon shares climbed notably amid the broader tech rally, underscoring investor focus on its role in the AI buildout. Observers noted the disconnect between spending giants and their suppliers in recent trading.

Retail Accumulation Trends: Discussions emphasized ongoing share buying on dips by market participants, tied to Amazon's expanding AWS AI capabilities and improving operational efficiencies. Price action showed consolidation after gains, with analysts watching for volume-supported rebounds near key levels. Long-term views centered on sustained growth in cloud and advertising segments.

Fundamental Inflection Points: Sentiment reflected cautious optimism around accelerating business momentum, including logistics enhancements and data advantages in emerging commerce areas. Recent price adjustments on select items drew brief attention but were overshadowed by broader positive technical setups. Overall, participants positioned the stock for potential upside from current supports.

Note: This discussion summary was generated from an AI condensation of post data.

Amazon Insider Trading Activity

Amazon insiders have traded $AMZN stock on the open market 64 times in the past 6 months. Of those trades, 0 have been purchases and 64 have been sales.

Here’s a breakdown of recent trading of $AMZN stock by insiders over the last 6 months:

JEFFREY P BEZOS (Executive Chair) sold 1,209,649 shares for an estimated $346,453,513
ANDREW R JASSY (President and CEO) has made 0 purchases and 11 sales selling 102,352 shares for an estimated $26,975,355.
DOUGLAS J HERRINGTON (CEO Worldwide Amazon Stores) has made 0 purchases and 20 sales selling 74,215 shares for an estimated $19,334,594.
MATTHEW S GARMAN (CEO Amazon Web Services) has made 0 purchases and 12 sales selling 41,483 shares for an estimated $10,854,849.
DAVID ZAPOLSKY (Senior Vice President) has made 0 purchases and 11 sales selling 30,880 shares for an estimated $8,121,596.
JONATHAN RUBINSTEIN has made 0 purchases and 2 sales selling 7,555 shares for an estimated $2,012,552.
BRIAN T OLSAVSKY (Senior Vice President and CFO) sold 6,172 shares for an estimated $1,606,633
SHELLEY REYNOLDS (Vice President) has made 0 purchases and 6 sales selling 4,706 shares for an estimated $1,226,857.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive AMZN Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

Amazon Revenue

Amazon had revenues of $200.6B in Q2 2026. This is an increase of 19.62% from the same period in the prior year.

You can track AMZN financials on Quiver Quantitative's AMZN stock page.

You can access data on AMZN stock through the Quiver Quantitative API.

Amazon Congressional Stock Trading

Members of Congress have traded $AMZN stock 14 times in the past 6 months. Of those trades, 6 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $AMZN stock by members of Congress over the last 6 months:

REPRESENTATIVE THOMAS H. KEAN, JR. purchased up to $15,000 on 07/08.
REPRESENTATIVE MICHAEL A. RULLI sold up to $15,000 on 06/25.
REPRESENTATIVE MATTHEW VAN EPPS sold up to $15,000 on 06/16.
REPRESENTATIVE DAVID TAYLOR sold up to $15,000 on 06/05.
REPRESENTATIVE DAN CRENSHAW sold up to $15,000 on 06/01.
REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 5 times. They made 3 purchases worth up to $45,000 on 04/22, 04/14, 03/16 and 2 sales worth up to $30,000 on 03/16, 03/13.
SENATOR JOHN FETTERMAN purchased up to $15,000 on 03/30.
SENATOR ALAN ARMSTRONG purchased up to $50,000 on 03/27.
REPRESENTATIVE MARK ALFORD sold up to $15,000 on 03/16.
REPRESENTATIVE JONATHAN L. JACKSON sold up to $15,000 on 03/09.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

Amazon Hedge Fund Activity

We have seen 3,222 institutional investors add shares of Amazon stock to their portfolio, and 2,630 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JPMORGAN CHASE & CO added 167,979,147 shares (+inf%) to their portfolio in Q2 2026, for an estimated $40,036,149,895
INVESCO LTD. added 86,675,127 shares (+151.7%) to their portfolio in Q2 2026, for an estimated $20,658,149,769
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 66,029,318 shares (+inf%) to their portfolio in Q2 2026, for an estimated $15,737,427,652
SG AMERICAS SECURITIES, LLC added 22,210,798 shares (+367.5%) to their portfolio in Q2 2026, for an estimated $5,293,721,595
ALLIANCEBERNSTEIN L.P. removed 14,917,149 shares (-28.3%) from their portfolio in Q2 2026, for an estimated $3,555,353,292
PRICE T ROWE ASSOCIATES INC /MD/ removed 14,091,485 shares (-11.5%) from their portfolio in Q2 2026, for an estimated $3,358,564,534
BLACKROCK, INC. added 12,838,547 shares (+1.7%) to their portfolio in Q2 2026, for an estimated $3,059,939,291

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

Amazon Analyst Ratings

Wall Street analysts have issued reports on $AMZN in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

RBC Capital issued a "Outperform" rating on 04/30/2026
Piper Sandler issued a "Overweight" rating on 04/30/2026
Guggenheim issued a "Buy" rating on 04/30/2026
Barclays issued a "Overweight" rating on 04/30/2026
Benchmark issued a "Buy" rating on 04/30/2026
Evercore ISI Group issued a "Outperform" rating on 04/30/2026
Wells Fargo issued a "Overweight" rating on 04/30/2026

To track analyst ratings and price targets for Amazon, check out Quiver Quantitative's $AMZN forecast page.

Amazon Price Targets

Multiple analysts have issued price targets for $AMZN recently. We have seen 29 analysts offer price targets for $AMZN in the last 6 months, with a median target of $320.0.

Here are some recent targets:

John Blackledge from TD Cowen set a target price of $340.0 on 07/08/2026
Ken Gawrelski from Wells Fargo set a target price of $313.0 on 07/02/2026
Youssef Squali from Truist Securities set a target price of $320.0 on 05/29/2026
Mark Kelley from Stifel set a target price of $319.0 on 05/01/2026
Daniel L. Kurnos from Benchmark set a target price of $370.0 on 04/30/2026
Maria Ripps from Canaccord Genuity set a target price of $330.0 on 04/30/2026
Joseph Feldman from Telsey Advisory Group set a target price of $315.0 on 04/30/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

Destiny Tech100 Stock (DXYZ) Opinions on Quarterly Earnings Release

39 minutes ago | Aug. 30, 2026 2:03 p.m. UTC

Earnings Update Issued: Destiny Tech100 released its second-quarter 2026 financial results on August 29, prompting investors to reassess the fund's portfolio of high-growth private technology holdings including stakes in Anthropic and OpenAI.

Valuation Discussions Heat Up: Market participants highlighted the challenges in estimating net asset value amid ongoing share sales above NAV and the potential impact of upcoming IPO activity on key holdings, with some noting substantial markups in prior rounds.

Portfolio Outlook Analyzed: Commentary focused on the fund's exposure to leading AI and tech unicorns, generating interest in how these assets might influence future performance without any direct price predictions from observers.

Note: This discussion summary was generated from an AI condensation of post data.

Destiny Tech100 Hedge Fund Activity

We have seen 97 institutional investors add shares of Destiny Tech100 stock to their portfolio, and 63 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

J. GOLDMAN & CO LP added 1,696,549 shares (+inf%) to their portfolio in Q2 2026, for an estimated $43,703,102
MORGAN STANLEY added 683,350 shares (+305.3%) to their portfolio in Q2 2026, for an estimated $17,603,096
SABA CAPITAL MANAGEMENT, L.P. added 644,280 shares (+inf%) to their portfolio in Q2 2026, for an estimated $16,596,652
SG AMERICAS SECURITIES, LLC added 550,249 shares (+inf%) to their portfolio in Q2 2026, for an estimated $14,174,414
SUSQUEHANNA INTERNATIONAL GROUP, LLP added 379,562 shares (+inf%) to their portfolio in Q2 2026, for an estimated $9,777,517
NEWTYN MANAGEMENT, LLC removed 345,000 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $8,887,200
ANSON FUNDS MANAGEMENT LP added 323,199 shares (+inf%) to their portfolio in Q2 2026, for an estimated $8,325,606

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

Tempus AI Stock (TEM) Opinions on Moderna Merck Cancer Vaccine News

39 minutes ago | Aug. 30, 2026 2:03 p.m. UTC

Vaccine Breakthrough Impact: Social media conversations have intensified around Tempus AI after the Phase 3 success reported by Moderna and Merck in personalized cancer vaccines. Observers point to the stock's notable gains as the development validates broader applications in precision oncology and sequencing technologies.

Growth Metrics Highlighted: Participants frequently reference recent revenue increases and new data licensing agreements as evidence of expanding market position. The intersection of artificial intelligence with healthcare diagnostics continues to draw attention in ongoing threads.

Platform Positioning Discussed: Analysts on social media emphasize Tempus's data capabilities and recent acquisitions as factors that could support long-term ecosystem involvement. Overall tone reflects sustained interest in the company's trajectory following these developments.

Note: This discussion summary was generated from an AI condensation of post data.

Tempus AI Insider Trading Activity

Tempus AI insiders have traded $TEM stock on the open market 103 times in the past 6 months. Of those trades, 0 have been purchases and 103 have been sales.

Here’s a breakdown of recent trading of $TEM stock by insiders over the last 6 months:

ERIC P LEFKOFSKY (CEO and Chairman) has made 0 purchases and 70 sales selling 1,319,926 shares for an estimated $68,723,000.
RYAN FUKUSHIMA (CEO, Data) has made 0 purchases and 13 sales selling 141,747 shares for an estimated $7,246,870.
JAMES WILLIAM ROGERS (Chief Financial Officer) has made 0 purchases and 4 sales selling 71,224 shares for an estimated $3,808,830.
ANDREW POLOVIN (EVP, Chief Legal Officer) has made 0 purchases and 3 sales selling 38,778 shares for an estimated $1,926,215.
THOMAS EDWARD SCHOENHERR (CEO, Diagnostics) has made 0 purchases and 8 sales selling 18,894 shares for an estimated $999,621.
RYAN M BARTOLUCCI (Chief Accounting Officer) has made 0 purchases and 2 sales selling 10,291 shares for an estimated $487,733.
JENNIFER A DOUDNA sold 2,673 shares for an estimated $147,015
DAVID R EPSTEIN has made 0 purchases and 2 sales selling 620 shares for an estimated $28,408.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive TEM Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

Tempus AI Revenue

Tempus AI had revenues of $382.5M in Q2 2026. This is an increase of 21.56% from the same period in the prior year.

You can track TEM financials on Quiver Quantitative's TEM stock page.

You can access data on TEM stock through the Quiver Quantitative API.

Tempus AI Hedge Fund Activity

We have seen 281 institutional investors add shares of Tempus AI stock to their portfolio, and 243 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JPMORGAN CHASE & CO added 4,989,062 shares (+inf%) to their portfolio in Q2 2026, for an estimated $289,016,361
GC WEALTH MANAGEMENT RIA, LLC removed 4,199,843 shares (-63.5%) from their portfolio in Q2 2026, for an estimated $243,296,904
GOLDMAN SACHS GROUP INC added 2,483,910 shares (+194.4%) to their portfolio in Q2 2026, for an estimated $143,892,906
CITADEL ADVISORS LLC added 1,911,096 shares (+317.8%) to their portfolio in Q2 2026, for an estimated $110,709,791
MORGAN STANLEY added 1,568,701 shares (+75.3%) to their portfolio in Q2 2026, for an estimated $90,874,848
BANK OF AMERICA CORP /DE/ added 1,502,992 shares (+362.4%) to their portfolio in Q2 2026, for an estimated $87,068,326
D. E. SHAW & CO., INC. removed 1,180,315 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $68,375,647

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

Tempus AI Government Contracts

We have seen $29,358,042 of award payments to $TEM over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

ADAPT CRO SUPPORT SERVICES SOLICITATION: $12,741,975

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

Tempus AI Price Targets

Multiple analysts have issued price targets for $TEM recently. We have seen 7 analysts offer price targets for $TEM in the last 6 months, with a median target of $64.0.

Here are some recent targets:

Gene Mannheimer from Freedom Capital Markets set a target price of $59.0 on 07/01/2026
Ryan MacDonald from Needham set a target price of $75.0 on 06/01/2026
Mark Massaro from BTIG set a target price of $80.0 on 06/01/2026
Yi Chen from HC Wainwright & Co. set a target price of $64.0 on 05/11/2026
Dan Brennan from TD Cowen set a target price of $68.0 on 05/06/2026
Tycho Peterson from Jefferies set a target price of $35.0 on 04/13/2026
Subbu Nambi from Guggenheim set a target price of $60.0 on 03/30/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

Alphabet Stock (GOOGL) Opinions on AI Growth Prospects

39 minutes ago | Aug. 30, 2026 2:03 p.m. UTC

AI Push Intensifies: Social media conversations center on Alphabet's accelerated AI development, including plans for monthly model releases and the training of Gemini 4 amid involvement from key leadership figures. Observers highlight the firm's commitment to frontier AI capabilities, drawing parallels to its historical innovations. Recent earnings underscored record net income levels exceeding $100 billion in a quarter.

Market Pullback Sparks Debate: Discussions note the stock's retreat to levels around $340 following earlier highs near $400, with some viewing the dip as an opportunity tied to expected growth above 30 percent. Analysts and participants reference ongoing deals in AI tools and infrastructure progress in areas like autonomous driving. Caution emerges around free cash flow impacts from heavy investments.

Sentiment Shifts Observed: Overall, social media sentiment reflects cautious optimism, as participants weigh AI tailwinds against short-term valuation pressures without signaling immediate reversals.

Note: This discussion summary was generated from an AI condensation of post data.

Alphabet Insider Trading Activity

Alphabet insiders have traded $GOOGL stock on the open market 76 times in the past 6 months. Of those trades, 0 have been purchases and 76 have been sales.

Here’s a breakdown of recent trading of $GOOGL stock by insiders over the last 6 months:

SUNDAR PICHAI (Chief Executive Officer) has made 0 purchases and 10 sales selling 65,000 shares for an estimated $19,866,079.
JOHN KENT WALKER (President, Global Affairs, CLO) has made 0 purchases and 13 sales selling 17,991 shares for an estimated $5,624,032.
JOHN L. HENNESSY has made 0 purchases and 43 sales selling 4,200 shares for an estimated $1,466,794.
AMIE THUENER O'TOOLE (VP, Chief Accounting Officer) has made 0 purchases and 2 sales selling 1,572 shares for an estimated $463,291.
MARSIDA SARACI (VP, Chief Accounting Officer) has made 0 purchases and 2 sales selling 898 shares for an estimated $303,039.
FRANCES ARNOLD has made 0 purchases and 6 sales selling 612 shares for an estimated $205,389.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

Alphabet Congressional Stock Trading

Members of Congress have traded $GOOGL stock 16 times in the past 6 months. Of those trades, 6 have been purchases and 10 have been sales.

Here’s a breakdown of recent trading of $GOOGL stock by members of Congress over the last 6 months:

REPRESENTATIVE MICHAEL A. RULLI has traded it 3 times. They made 2 purchases worth up to $30,000 on 06/29, 06/25 and 1 sale worth up to $100,000 on 08/24.
REPRESENTATIVE DAVID TAYLOR has traded it 6 times. They made 4 purchases worth up to $60,000 on 08/11, 07/17, 06/05 and 2 sales worth up to $65,000 on 05/15.
REPRESENTATIVE THOMAS H. KEAN, JR. has traded it 3 times. They made 0 purchases and 3 sales worth up to $80,000 on 07/22, 06/24, 06/02.
REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 07/10.
REPRESENTATIVE MATTHEW VAN EPPS sold up to $15,000 on 06/16.
REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 05/05.
REPRESENTATIVE LIZZIE FLETCHER sold up to $15,000 on 04/08.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

Alphabet Hedge Fund Activity

We have seen 2,612 institutional investors add shares of Alphabet stock to their portfolio, and 2,861 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JPMORGAN CHASE & CO added 91,919,476 shares (+inf%) to their portfolio in Q2 2026, for an estimated $32,849,263,138
INVESCO LTD. added 45,433,998 shares (+99.1%) to their portfolio in Q2 2026, for an estimated $16,236,747,865
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 40,980,558 shares (+inf%) to their portfolio in Q2 2026, for an estimated $14,645,222,012
BERKSHIRE HATHAWAY INC added 24,541,369 shares (+45.2%) to their portfolio in Q2 2026, for an estimated $8,770,349,039
PRICE T ROWE ASSOCIATES INC /MD/ added 20,809,301 shares (+25.8%) to their portfolio in Q2 2026, for an estimated $7,436,619,898
NORGES BANK removed 16,622,060 shares (-17.0%) from their portfolio in Q2 2026, for an estimated $5,940,225,582
FMR LLC added 14,169,330 shares (+6.0%) to their portfolio in Q2 2026, for an estimated $5,063,693,462

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

Alphabet Government Contracts

We have seen $7,992,076 of award payments to $GOOGL over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

STRATUS POOL 1 CLOUD SERVICE BOA TO FOR GOOGLE CLOUD SERVICE PROVIDER CORE SERVICES: $7,992,076

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

Alphabet Analyst Ratings

Wall Street analysts have issued reports on $GOOGL in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Needham issued a "Buy" rating on 05/20/2026
Piper Sandler issued a "Overweight" rating on 04/30/2026
RBC Capital issued a "Outperform" rating on 04/30/2026
Guggenheim issued a "Buy" rating on 04/30/2026
Evercore ISI Group issued a "Outperform" rating on 04/30/2026
Barclays issued a "Overweight" rating on 04/30/2026

To track analyst ratings and price targets for Alphabet, check out Quiver Quantitative's $GOOGL forecast page.

Alphabet Price Targets

Multiple analysts have issued price targets for $GOOGL recently. We have seen 23 analysts offer price targets for $GOOGL in the last 6 months, with a median target of $425.0.

Here are some recent targets:

Ken Gawrelski from Wells Fargo set a target price of $416.0 on 07/02/2026
Brian Nowak from Morgan Stanley set a target price of $415.0 on 06/30/2026
Laura Martin from Needham set a target price of $450.0 on 06/03/2026
Paul Rossington from HSBC set a target price of $420.0 on 06/02/2026
Thomas Champion from Piper Sandler set a target price of $445.0 on 06/01/2026
Youssef Squali from Truist Securities set a target price of $430.0 on 05/29/2026
Barton Crockett from Rosenblatt set a target price of $393.0 on 05/21/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

Broadcom Stock (AVGO) Opinions on Upcoming Earnings and AI Chip Developments

39 minutes ago | Aug. 30, 2026 2:03 p.m. UTC

Earnings spotlight: Market participants on social media are zeroing in on Broadcom's upcoming quarterly results, with particular attention to its AI semiconductor revenue guidance amid strong hyperscaler demand.

Custom chip momentum: Discussions highlight recent advancements in tailored AI accelerators, including partnerships that position the company to deliver substantial efficiency gains over standard solutions in inference workloads.

Sector context: Observers note the stock's recent consolidation while emphasizing sustained interest in its networking and data center offerings as earnings season tests broader AI investment trends.

Note: This discussion summary was generated from an AI condensation of post data.

Broadcom Insider Trading Activity

Broadcom insiders have traded $AVGO stock on the open market 149 times in the past 6 months. Of those trades, 1 have been purchases and 148 have been sales.

Here’s a breakdown of recent trading of $AVGO stock by insiders over the last 6 months:

HENRY SAMUELI has made 0 purchases and 38 sales selling 1,436,208 shares for an estimated $500,006,153.
MARK DAVID BRAZEAL (Chief Legal & Corp Affairs Ofc) has made 0 purchases and 48 sales selling 166,834 shares for an estimated $59,425,537.
S. RAM VELAGA (President, ISG) has made 0 purchases and 21 sales selling 102,594 shares for an estimated $34,421,293.
CHARLIE B KAWWAS (President, SSG) has made 0 purchases and 19 sales selling 74,834 shares for an estimated $24,418,944.
KIRSTEN M. SPEARS (CFO & Chief Accounting Officer) has made 0 purchases and 18 sales selling 60,154 shares for an estimated $19,452,715.
JUSTINE PAGE has made 0 purchases and 2 sales selling 3,620 shares for an estimated $1,311,269.
GAYLA J DELLY has made 0 purchases and 2 sales selling 2,890 shares for an estimated $1,086,678.
HARRY L. YOU purchased 1,000 shares for an estimated $373,570

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive AVGO Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

Broadcom Revenue

Broadcom had revenues of $22.2B in Q2 2026. This is an increase of 47.87% from the same period in the prior year.

You can track AVGO financials on Quiver Quantitative's AVGO stock page.

You can access data on AVGO stock through the Quiver Quantitative API.

Broadcom Congressional Stock Trading

Members of Congress have traded $AVGO stock 8 times in the past 6 months. Of those trades, 3 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $AVGO stock by members of Congress over the last 6 months:

REPRESENTATIVE DAVID TAYLOR has traded it 3 times. They made 1 purchase worth up to $15,000 on 07/24 and 2 sales worth up to $30,000 on 04/27.
REPRESENTATIVE RICK W. ALLEN purchased up to $15,000 on 07/14.
SENATOR SHELLEY MOORE CAPITO sold up to $15,000 on 04/13.
REPRESENTATIVE JARED MOSKOWITZ purchased up to $15,000 on 03/31.
SENATOR ALAN ARMSTRONG sold up to $50,000 on 03/27.
REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 03/25.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

Broadcom Hedge Fund Activity

We have seen 2,598 institutional investors add shares of Broadcom stock to their portfolio, and 2,147 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JPMORGAN CHASE & CO added 95,016,148 shares (+inf%) to their portfolio in Q2 2026, for an estimated $35,892,349,907
INVESCO LTD. added 35,875,676 shares (+107.7%) to their portfolio in Q2 2026, for an estimated $13,552,036,609
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 33,404,003 shares (+inf%) to their portfolio in Q2 2026, for an estimated $12,618,362,133
FMR LLC added 20,246,297 shares (+16.3%) to their portfolio in Q2 2026, for an estimated $7,648,038,691
BLACKROCK, INC. added 12,269,052 shares (+3.2%) to their portfolio in Q2 2026, for an estimated $4,634,634,393
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 10,145,294 shares (-54.1%) from their portfolio in Q2 2026, for an estimated $3,832,384,808
SG AMERICAS SECURITIES, LLC removed 7,595,730 shares (-35.6%) from their portfolio in Q2 2026, for an estimated $2,869,287,007

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

Broadcom Government Contracts

We have seen $79,942,925 of award payments to $AVGO over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

NEW 66 MONTH OPEN-MARKET CONTRACT FOR RENEWAL OF CA SOFTWARE, SUPPORT SERVICES, AND MAINTENANCE. CA PROPRIE...: $55,423,123
CA SOFTWARE MAINTENANCE: $22,168,426
BROADCOM IDIQ TASK ORDER FOR CLARITY INVESTMENT MANAGEMENT TOOL (IMT) SUPPORT SERVICES.: $885,600
INDEFINITE DELIVERY INDEFINITE QUANTITY (IDIQ) CONTRACT FOR EXPERT LEVEL ENGINEERS, PRODUCT SPECIALIST, AND...: $761,328

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

Broadcom Analyst Ratings

Wall Street analysts have issued reports on $AVGO in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Deutsche Bank issued a "Buy" rating on 06/04/2026
UBS issued a "Buy" rating on 06/04/2026

To track analyst ratings and price targets for Broadcom, check out Quiver Quantitative's $AVGO forecast page.

Broadcom Price Targets

Multiple analysts have issued price targets for $AVGO recently. We have seen 21 analysts offer price targets for $AVGO in the last 6 months, with a median target of $525.0.

Here are some recent targets:

Ross Seymore from Deutsche Bank set a target price of $515.0 on 06/04/2026
Cody Acree from Benchmark set a target price of $545.0 on 06/04/2026
Gil Luria from DA Davidson set a target price of $400.0 on 06/04/2026
Arthur Lai from Macquarie set a target price of $437.0 on 06/04/2026
Rick Schafer from Oppenheimer set a target price of $535.0 on 06/04/2026
Vijay Rakesh from Mizuho set a target price of $530.0 on 06/04/2026
Vivek Arya from B of A Securities set a target price of $530.0 on 06/04/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

Press Release: Hakeem Jeffries discusses affordability, tariffs and voting rights on MS NOW

14 hours ago | Aug. 30, 2026 12:20 a.m. UTC

Hakeem Jeffries discussed affordability, criticizing Republicans and outlining Democratic priorities on costs, voting rights, and congressional control.

Quiver AI Summary

Jeffries on MS NOW: House Democratic Leader Hakeem Jeffries said on MSNBC’s PoliticsNation that House Democrats are focused on lowering living costs and addressing what he called an “affordability crisis.” He linked rising prices to Republican policies and said Democrats are committed to making groceries, gas, housing and health care more affordable.

Policy and elections: In the interview, Jeffries criticized Trump administration trade and foreign policy decisions, arguing they have increased costs and lacked clear goals. He also said Democrats are preparing a broad voter-protection effort and want to oppose what he described as attempts to restrict voting and redraw districts affecting Black representation.

Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.

Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.

Hakeem S. Jeffries Fundraising

Hakeem S. Jeffries recently disclosed $877.2K of fundraising in a Q2 FEC disclosure filed on July 15th, 2026. This was the 78th most from all Q2 reports we have seen this year. 61.8% came from individual donors.

Jeffries disclosed $851.8K of spending. This was the 107th most from all Q2 reports we have seen from politicians so far this year.

Jeffries disclosed $5.0M of cash on hand at the end of the filing period. This was the 62nd most from all Q2 reports we have seen this year.

You can see the disclosure here, or track Hakeem S. Jeffries's fundraising on Quiver Quantitative.

Hakeem S. Jeffries Net Worth

Quiver Quantitative estimates that Hakeem S. Jeffries is worth $667.2K, as of August 30th, 2026. This is the 382nd highest net worth in Congress, per our live estimates.

Jeffries has approximately $202.2K invested in publicly traded assets which Quiver is able to track live.

You can track Hakeem S. Jeffries's net worth on Quiver Quantitative's politician page for Jeffries.

Hakeem S. Jeffries Bill Proposals

Here are some bills which have recently been proposed by Hakeem S. Jeffries:

H.R.19: Reserved for the Minority Leader.
H.R.18: Reserved for the Minority Leader.
H.R.13: Reserved for the Minority Leader.

You can track bills proposed by Hakeem S. Jeffries on Quiver Quantitative's politician page for Jeffries.

2026 New York's 8th Congressional District Election

There has been approximately $20,231,361 of spending in New York's 8th congressional district elections over the last two years, per our estimates.

Approximately $32,100 of this has been from outside spending by PACs and Super PACs.

The rating for this race is currently "Solid D".

You can track this election on our matchup page for the 2026 New York's 8th congressional district election.

Read Full Article

CANGO Q2 2026 Earnings Preview: Recent $CANG Insider Trading, Hedge Fund Activity, and More

17 hours ago | Aug. 29, 2026 9:05 p.m. UTC

CANGO ($CANG) is expected to release its quarterly earnings data on Monday, August 31st after market close, per Finnhub. Analysts are expecting revenue of $104,009,400 and earnings of -$0.92 per share.

You can see Quiver Quantitative's $CANG stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

CANGO Hedge Fund Activity

We have seen 19 institutional investors add shares of CANGO stock to their portfolio, and 27 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

UBS GROUP AG removed 969,649 shares (-90.1%) from their portfolio in Q2 2026, for an estimated $1,982,932
RENAISSANCE TECHNOLOGIES LLC removed 894,612 shares (-88.6%) from their portfolio in Q2 2026, for an estimated $1,829,481
BLACKROCK, INC. removed 471,622 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $964,466
MILLENNIUM MANAGEMENT LLC removed 347,131 shares (-60.5%) from their portfolio in Q2 2026, for an estimated $709,882
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. added 278,757 shares (+inf%) to their portfolio in Q2 2026, for an estimated $570,058
INVESCO LTD. removed 266,669 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $545,338
GOLDMAN SACHS GROUP INC added 234,146 shares (+inf%) to their portfolio in Q2 2026, for an estimated $478,828

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

PYXIS TANKERS Q2 2026 Earnings Preview: Recent $PXS Insider Trading, Hedge Fund Activity, and More

17 hours ago | Aug. 29, 2026 9:05 p.m. UTC

PYXIS TANKERS ($PXS) is expected to release its quarterly earnings data on Monday, August 31st after market close, per Finnhub. Analysts are expecting revenue of $11,493,800 and earnings of $0.20 per share.

You can see Quiver Quantitative's $PXS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

EARLY ACCESS

Receive PXS Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

PYXIS TANKERS Hedge Fund Activity

We have seen 5 institutional investors add shares of PYXIS TANKERS stock to their portfolio, and 7 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

NEWEDGE ADVISORS, LLC added 39,527 shares (+inf%) to their portfolio in Q2 2026, for an estimated $164,432
HRT FINANCIAL LP added 18,267 shares (+inf%) to their portfolio in Q2 2026, for an estimated $75,990
TWO SIGMA SECURITIES, LLC removed 17,888 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $75,845
SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 15,070 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $62,691
CITADEL ADVISORS LLC removed 13,161 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $54,749
XTX TOPCO LTD removed 10,307 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $43,701
FOCUS PARTNERS WEALTH removed 9,324 shares (-38.3%) from their portfolio in Q2 2026, for an estimated $38,787

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

Insider Stock Purchases: August 29, 2026

19 hours ago | Aug. 29, 2026 6:45 p.m. UTC

We have seen 44 open market insider transactions reported today, August 29, 2026. You can track them all on the Quiver Quantitative Insider Trading dashboard. Here are some of the largest open market insider stock purchases we have seen.

OPTIMUM COMMUNICATIONS, INC. ($OPTU)

SUBIN NEIL S bought 1,291,471 shares on 08/19 for an estimated $1,083,673.

Past $OPTU Insider Trades

OPTIMUM COMMUNICATIONS, INC. insiders have traded $OPTU stock on the open market 14 times in the past 6 months. Of those trades, 8 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $OPTU stock by insiders over the last 6 months:

NEIL S SUBIN has made 8 purchases buying 3,032,354 shares for an estimated $2,454,821 and 0 sales.
MICHAEL OLSEN (General Counsel and CCRO) has made 0 purchases and 6 sales selling 120,000 shares for an estimated $140,400.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

SITEONE LANDSCAPE SUPPLY, INC. ($SITE)

BLACK DOUG (CEO) bought 5,000 shares on 08/26 for an estimated $480,650.

Past $SITE Insider Trades

SITEONE LANDSCAPE SUPPLY, INC. insiders have traded $SITE stock on the open market 5 times in the past 6 months. Of those trades, 3 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $SITE stock by insiders over the last 6 months:

DOUG BLACK (CEO) has made 3 purchases buying 13,000 shares for an estimated $1,296,930 and 0 sales.
FRED M DIAZ has made 0 purchases and 2 sales selling 1,125 shares for an estimated $128,054.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

UNITED STATES ANTIMONY CORP ($UAMY)

EVANS GARY C (Chairman & CEO) bought 20,000 shares on 08/28 for an estimated $98,400.

Past $UAMY Insider Trades

UNITED STATES ANTIMONY CORP insiders have traded $UAMY stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $UAMY stock by insiders over the last 6 months:

GARY C EVANS (Chairman & CEO) purchased 20,000 shares for an estimated $98,400
JON R MARINELLI purchased 12,500 shares for an estimated $93,125

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

BIOVIE INC. ($BIVI)

DO CUONG V (President & CEO) bought 15,210 shares on 08/27 for an estimated $31,636.

Past $BIVI Insider Trades

BIOVIE INC. insiders have traded $BIVI stock on the open market 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $BIVI stock by insiders over the last 6 months:

CUONG V DO (President & CEO) purchased 15,210 shares for an estimated $31,636
JOSEPH M PALUMBO (Chief Medical Officer) purchased 4,843 shares for an estimated $10,460
JOANNE WENDY KIM (Chief Financial Officer) purchased 2,500 shares for an estimated $5,450
AMY SUZON CHAPPELL purchased 727 shares for an estimated $1,570

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Read Full Article

Press Release: Al Green highlights Fox 26 Houston report on impeachment articles over ICE operations

20 hours ago | Aug. 29, 2026 6:20 p.m. UTC

Congressman Green highlights a Fox 26 Houston article on Texas lawmakers and community leaders supporting impeachment articles over ICE operations.

Quiver AI Summary

Press release summary: Congressman Al Green’s office shared a Fox 26 Houston article titled “Texas lawmakers, community leaders back impeachment articles over ICE enforcement operations.” The release does not add new details, saying only that the article “speaks for itself.”

Link provided: The post directs readers to the Fox 26 Houston story for more information.

Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.

Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.

Al Green Fundraising

Al Green recently disclosed $106.0K of fundraising in a Q2 FEC disclosure filed on July 15th, 2026. This was the 712th most from all Q2 reports we have seen this year. 95.3% came from individual donors.

Green disclosed $456.0K of spending. This was the 220th most from all Q2 reports we have seen from politicians so far this year.

Green disclosed $84.8K of cash on hand at the end of the filing period. This was the 989th most from all Q2 reports we have seen this year.

You can see the disclosure here, or track Al Green's fundraising on Quiver Quantitative.

Al Green Net Worth

Quiver Quantitative estimates that Al Green is worth $5.7M, as of August 29th, 2026. This is the 160th highest net worth in Congress, per our live estimates.

Green has approximately $0 invested in publicly traded assets which Quiver is able to track live.

You can track Al Green's net worth on Quiver Quantitative's politician page for Green.

Al Green Bill Proposals

Here are some bills which have recently been proposed by Al Green:

H.R.9579: Department of Homeland Security Office for Civil Rights and Civil Liberties Authorization Act
H.R.8647: Representative Green's Original Legislation to increase from 9 to 13 the number of justices of the Supreme Court.
H.R.8411: Original Legislation to Give TSA Employees a Raise
H.R.8318: Original Additional Credit FHA Pilot Program Authorization Act
H.R.8292: Original Alternative Data for Additional Credit FHA Pilot Program Reauthorization Act
H.R.8291: Reforming Disaster Recovery Act

You can track bills proposed by Al Green on Quiver Quantitative's politician page for Green.

2026 Texas's 18th Congressional District Election

There has been approximately $21,127,133 of spending in Texas's 18th congressional district elections over the last two years, per our estimates.

Approximately $7,188,070 of this has been from outside spending by PACs and Super PACs. Some of the groups who are spending money in this race include:

PROTECT PROGRESS ($6,515,238)
LEADERS WE DESERVE ($286,584)
PROJECT 218 ($199,999)
CONGRESSIONAL PROGRESSIVE CAUCUS PAC ($100,000)
RESISTANCE PAC ($79,210)

The rating for this race is currently "Solid D".

You can track this election on our matchup page for the 2026 Texas's 18th congressional district election.

Read Full Article

Press Release: Pablo José Hernández Rivera backs bill to support gaming and virtual reality jobs

20 hours ago | Aug. 29, 2026 6:20 p.m. UTC

Pablo José Hernández Rivera backs federal legislation funding VR, AR, and gaming-based workforce training in Puerto Rico.

Quiver AI Summary

Hernández Rivera backs workforce bill: Resident Commissioner Pablo José Hernández Rivera said he supports federal legislation that would create a program for job skills development using virtual reality, augmented reality and other immersive technologies. The bill, H.R. 6968, would provide $50 million a year for workforce training tied to gaming and virtual reality.

Announcement made at GAMERGYPR: Hernández Rivera made the announcement at GAMERGYPR 2026 in San Juan, where he said the gaming and technology sectors could offer economic opportunities for Puerto Rico, especially for young people. He also cited industry employment and economic figures and noted the bill has backing from several workforce and XR groups.

Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.

Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.

Pablo Hernández Fundraising

Pablo Hernández recently disclosed $287.5K of fundraising in a Q2 FEC disclosure filed on July 15th, 2026. This was the 348th most from all Q2 reports we have seen this year. 98.1% came from individual donors.

Hernández disclosed $65.6K of spending. This was the 964th most from all Q2 reports we have seen from politicians so far this year.

Hernández disclosed $541.8K of cash on hand at the end of the filing period. This was the 553rd most from all Q2 reports we have seen this year.

You can see the disclosure here, or track Pablo Hernández's fundraising on Quiver Quantitative.

Pablo Hernández Net Worth

Quiver Quantitative estimates that Pablo Hernández is worth $1.2M, as of August 29th, 2026. This is the 314th highest net worth in Congress, per our live estimates.

Hernández has approximately $106.8K invested in publicly traded assets which Quiver is able to track live.

You can track Pablo Hernández's net worth on Quiver Quantitative's politician page for Hernández.

Pablo Hernández Bill Proposals

Here are some bills which have recently been proposed by Pablo Hernández:

H.R.9595: Sergeant First Class Jorge Otero Barreto Medal of Honor Act
H.R.9246: Puerto Rico Democratic Self Determination Act
H.R.7829: Disaster Aid Without Delay Act of 2026
H.R.7697: International AI Energy Grid Modernization Strategy Act
H.R.7696: AI Cyber Grid Protection Resilient Development Act of 2026
H.R.7397: Puerto Rico Water Infrastructure Resilience Act

You can track bills proposed by Pablo Hernández on Quiver Quantitative's politician page for Hernández.

2028 None's 0th Congressional District Election

There has been approximately $2,253,906 of spending in None's 0th congressional district elections over the last two years, per our estimates.

You can track this election on our matchup page for the 2028 None's 0th congressional district election.

Read Full Article

Klarna Stock (KLAR) Opinions on CEO Insider Purchase and Earnings Update

21 hours ago | Aug. 29, 2026 5:33 p.m. UTC

CEO Share Purchase: Market observers on social media have highlighted a substantial open-market acquisition by Klarna's chief executive, who added nearly $10 million in shares at around $14.37 each. This move follows a period of stock volatility after recent earnings that included a guidance adjustment. Discussions note the CEO's increased stake as a signal of commitment amid ongoing growth in revenue metrics.

Earnings and Outlook: Commentary has centered on Klarna's latest quarterly results showing strong year-over-year gains in operating income and consumer activity. Some participants point to expanding partnerships, including with major retailers, as potential catalysts despite prior guidance revisions. The overall tone reflects interest in how these factors may influence near-term performance.

Note: This discussion summary was generated from an AI condensation of post data.

Klarna Insider Trading Activity

Klarna insiders have traded $KLAR stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $KLAR stock by insiders over the last 6 months:

SEBASTIAN SIEMIATKOWSKI (Chief Executive Officer) purchased 692,506 shares for an estimated $9,949,164

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

Klarna Hedge Fund Activity

We have seen 127 institutional investors add shares of Klarna stock to their portfolio, and 135 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

HMI CAPITAL MANAGEMENT, L.P. removed 4,123,719 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $83,464,072
JPMORGAN CHASE & CO added 4,010,356 shares (+inf%) to their portfolio in Q2 2026, for an estimated $81,169,605
PICTET ASSET MANAGEMENT HOLDING SA added 3,520,836 shares (+244.2%) to their portfolio in Q2 2026, for an estimated $71,261,720
BLACKROCK, INC. added 2,693,374 shares (+89.6%) to their portfolio in Q2 2026, for an estimated $54,513,889
AMERIPRISE FINANCIAL INC added 2,479,021 shares (+13047.5%) to their portfolio in Q2 2026, for an estimated $50,175,385
HRT FINANCIAL LP added 2,162,698 shares (+1135.9%) to their portfolio in Q2 2026, for an estimated $43,773,007
MILLENNIUM MANAGEMENT LLC added 1,950,866 shares (+237.4%) to their portfolio in Q2 2026, for an estimated $39,485,527

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

Klarna Price Targets

Multiple analysts have issued price targets for $KLAR recently. We have seen 12 analysts offer price targets for $KLAR in the last 6 months, with a median target of $23.0.

Here are some recent targets:

Will Nance from Goldman Sachs set a target price of $25.0 on 07/09/2026
Nik Cremo from Barclays set a target price of $20.0 on 07/08/2026
Tien-Tsin Huang from JP Morgan set a target price of $22.0 on 07/08/2026
Timothy Chiodo from UBS set a target price of $23.0 on 07/08/2026
Moshe Orenbuch from TD Cowen set a target price of $19.0 on 07/07/2026
Nate Svensson from Deutsche Bank set a target price of $27.0 on 07/02/2026
Lemar Clarke from Freedom Broker set a target price of $25.0 on 06/25/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

Rivian Automotive Stock (RIVN) Opinions on R2 Reviews and Analyst Ratings

21 hours ago | Aug. 29, 2026 5:33 p.m. UTC

R2 Model Excels in Tests: Social media chatter highlights Rivian’s R2 SUV outperforming rivals in a MotorTrend comparison, praised for its blend of style, space, and performance. Observers note strong order conversion rates following initial deliveries, which could support production ramp-ups later this year.

Analyst Sentiment Holds Steady: Recent commentary points to Stifel reiterating a Buy rating with a $22 target after the company exceeded its EBITDA forecast. Discussions also reference a pending CFO transition and ongoing self-driving technology milestones expected by year-end.

Options Activity Draws Focus: Market participants examine technical levels near $15 to $17, with stabilizing nodes seen as potential support amid volatility. Portfolio tracking posts underscore large institutional holdings tied to Amazon’s ongoing relationship with the electric vehicle maker.

Note: This discussion summary was generated from an AI condensation of post data.

Rivian Automotive Insider Trading Activity

Rivian Automotive insiders have traded $RIVN stock on the open market 15 times in the past 6 months. Of those trades, 2 have been purchases and 13 have been sales.

Here’s a breakdown of recent trading of $RIVN stock by insiders over the last 6 months:

AG VOLKSWAGEN purchased 62,889,522 shares for an estimated $999,943,399
ROBERT J SCARINGE (Chief Executive Officer) has made 0 purchases and 5 sales selling 111,428 shares for an estimated $1,706,992.
CLAIRE MCDONOUGH (Chief Financial Officer) has made 0 purchases and 7 sales selling 60,601 shares for an estimated $957,073.
KAREN BOONE sold 20,000 shares for an estimated $400,000
AIDAN N. GOMEZ purchased 18,000 shares for an estimated $251,460

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

Rivian Automotive Revenue

Rivian Automotive had revenues of $1.7B in Q2 2026. This is an increase of 27.24% from the same period in the prior year.

You can track RIVN financials on Quiver Quantitative's RIVN stock page.

You can access data on RIVN stock through the Quiver Quantitative API.

Rivian Automotive Hedge Fund Activity

We have seen 399 institutional investors add shares of Rivian Automotive stock to their portfolio, and 362 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JPMORGAN CHASE & CO added 22,651,249 shares (+inf%) to their portfolio in Q2 2026, for an estimated $392,999,170
SLATE PATH CAPITAL LP added 21,978,400 shares (+inf%) to their portfolio in Q2 2026, for an estimated $381,325,240
UBER TECHNOLOGIES, INC added 19,553,911 shares (+inf%) to their portfolio in Q2 2026, for an estimated $339,260,355
TWO SIGMA INVESTMENTS, LP added 9,624,687 shares (+100.7%) to their portfolio in Q2 2026, for an estimated $166,988,319
D. E. SHAW & CO., INC. added 7,178,013 shares (+52.6%) to their portfolio in Q2 2026, for an estimated $124,538,525
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 5,737,795 shares (+inf%) to their portfolio in Q2 2026, for an estimated $99,550,743
MARSHALL WACE, LLP added 3,512,799 shares (+96.1%) to their portfolio in Q2 2026, for an estimated $60,947,062

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

Rivian Automotive Analyst Ratings

Wall Street analysts have issued reports on $RIVN in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Needham issued a "Buy" rating on 06/10/2026

To track analyst ratings and price targets for Rivian Automotive, check out Quiver Quantitative's $RIVN forecast page.

Rivian Automotive Price Targets

Multiple analysts have issued price targets for $RIVN recently. We have seen 10 analysts offer price targets for $RIVN in the last 6 months, with a median target of $21.0.

Here are some recent targets:

Joseph Spak from UBS set a target price of $17.0 on 07/09/2026
James Picariello from BNP Paribas set a target price of $24.0 on 07/08/2026
Philippe Houchois from Jefferies set a target price of $17.0 on 07/07/2026
Chris Pierce from Needham set a target price of $23.0 on 06/10/2026
Itay Michaeli from TD Cowen set a target price of $20.0 on 06/03/2026
Michael Shlisky from DA Davidson set a target price of $15.0 on 05/11/2026
Mickey Legg from Benchmark set a target price of $25.0 on 05/01/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

Apple Stock (AAPL) Opinions on Tim Cook's CEO Transition

21 hours ago | Aug. 29, 2026 5:33 p.m. UTC

CEO Transition Buzz: Social media chatter intensified around the upcoming leadership shift at Apple as Tim Cook prepares to step down. Participants highlighted his long-term record of expanding the company's market value significantly during his tenure. Some expressed curiosity about how the incoming executive might navigate ongoing product cycles.

Earnings and Guidance Reactions: Recent quarterly results showing iPhone revenue growth drew measured commentary, though guidance for the September period was viewed as softer than anticipated. Traders noted potential for sustained momentum if new device launches maintain upward trends amid easing supply issues. Overall views reflected a focus on execution risks ahead.

Market Positioning Notes: Discussions also touched on the stock's recent pullback from highs, with emphasis on key support levels and defensive qualities in volatile conditions. Observers pointed to the balance sheet strength as a potential stabilizer amid broader tech sector swings. Sentiment remained mixed as participants weighed legacy achievements against forward uncertainties.

Note: This discussion summary was generated from an AI condensation of post data.

Apple Insider Trading Activity

Apple insiders have traded $AAPL stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.

Here’s a breakdown of recent trading of $AAPL stock by insiders over the last 6 months:

TIMOTHY D COOK (Chief Executive Officer) has made 0 purchases and 6 sales selling 64,949 shares for an estimated $16,512,197.
ARTHUR D LEVINSON sold 50,000 shares for an estimated $15,551,000
DEIRDRE O'BRIEN (Senior Vice President) has made 0 purchases and 2 sales selling 30,002 shares for an estimated $7,660,875.
JENNIFER NEWSTEAD (SVP, GC and Secretary) has made 0 purchases and 3 sales selling 4,317 shares for an estimated $1,332,787.
KEVAN PAREKH (Senior Vice President, CFO) sold 1,534 shares for an estimated $421,850
BEN BORDERS (Principal Accounting Officer) sold 116 shares for an estimated $34,236

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

Apple Revenue

Apple had revenues of $109.4B in Q3 2026. This is an increase of 16.36% from the same period in the prior year.

You can track AAPL financials on Quiver Quantitative's AAPL stock page.

You can access data on AAPL stock through the Quiver Quantitative API.

Apple Congressional Stock Trading

Members of Congress have traded $AAPL stock 19 times in the past 6 months. Of those trades, 7 have been purchases and 12 have been sales.

Here’s a breakdown of recent trading of $AAPL stock by members of Congress over the last 6 months:

REPRESENTATIVE ED CASE has traded it 2 times. They made 2 purchases worth up to $30,000 on 08/13, 05/14 and 0 sales.
REPRESENTATIVE RICHARD MCCORMICK sold up to $15,000 on 07/30.
SENATOR SHELLEY MOORE CAPITO has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 07/21, 04/17.
REPRESENTATIVE MICHAEL A. RULLI sold up to $15,000 on 06/25.
SENATOR SHELDON WHITEHOUSE has traded it 2 times. They made 0 purchases and 2 sales worth up to $100,000 on 06/24.
REPRESENTATIVE MATTHEW VAN EPPS sold up to $15,000 on 06/16.
REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 06/05.
REPRESENTATIVE DAN CRENSHAW sold up to $15,000 on 06/01.
REPRESENTATIVE DAVID TAYLOR has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 05/15.
REPRESENTATIVE CLEO FIELDS purchased up to $15,000 on 05/14.
REPRESENTATIVE JOHN MCGUIRE purchased up to $15,000 on 04/15.
REPRESENTATIVE LIZZIE FLETCHER sold up to $15,000 on 04/08.
SENATOR ALAN ARMSTRONG has traded it 2 times. They made 2 purchases worth up to $515,000 on 03/30, 03/27 and 0 sales.
REPRESENTATIVE MARK ALFORD sold up to $15,000 on 03/16.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

Apple Hedge Fund Activity

We have seen 2,728 institutional investors add shares of Apple stock to their portfolio, and 3,152 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JPMORGAN CHASE & CO added 228,762,008 shares (+inf%) to their portfolio in Q2 2026, for an estimated $66,194,574,634
INVESCO LTD. added 115,074,631 shares (+157.9%) to their portfolio in Q2 2026, for an estimated $33,297,995,226
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 101,374,121 shares (+inf%) to their portfolio in Q2 2026, for an estimated $29,333,615,652
PRICE T ROWE ASSOCIATES INC /MD/ removed 40,615,258 shares (-20.3%) from their portfolio in Q2 2026, for an estimated $11,752,431,054
DIAMANT ASSET MANAGEMENT, INC. removed 26,511,904 shares (-99.6%) from their portfolio in Q2 2026, for an estimated $7,671,484,541
FRANKLIN RESOURCES INC added 20,599,001 shares (+42.4%) to their portfolio in Q2 2026, for an estimated $5,960,526,929
CORIENT PRIVATE WEALTH LLC removed 19,792,183 shares (-65.5%) from their portfolio in Q1 2026, for an estimated $4,954,775,092

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

Apple Analyst Ratings

Wall Street analysts have issued reports on $AAPL in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Morgan Stanley issued a "Overweight" rating on 05/01/2026

To track analyst ratings and price targets for Apple, check out Quiver Quantitative's $AAPL forecast page.

Apple Price Targets

Multiple analysts have issued price targets for $AAPL recently. We have seen 15 analysts offer price targets for $AAPL in the last 6 months, with a median target of $350.0.

Here are some recent targets:

Amit Daryanani from Evercore ISI Group set a target price of $365.0 on 06/25/2026
An analyst from KGI Securities set a target price of $315.0 on 06/22/2026
Wamsi Mohan from B of A Securities set a target price of $380.0 on 06/18/2026
Erik Woodring from Morgan Stanley set a target price of $360.0 on 06/09/2026
Krish Sankar from TD Cowen set a target price of $350.0 on 06/09/2026
Tom Forte from Maxim Group set a target price of $350.0 on 06/09/2026
Barton Crockett from Rosenblatt set a target price of $276.0 on 06/09/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

Pinterest Stock (PINS) Opinions on Recent Earnings and AI Strategies

21 hours ago | Aug. 29, 2026 5:33 p.m. UTC

AI Cost Advantages: Social media chatter highlights Pinterest's use of open-source models post-trained on proprietary data, which executives claim cuts costs significantly compared to closed alternatives. Analysts on the platform note this approach could enhance margins amid broader industry shifts toward efficiency. Discussions emphasize how such strategies position the company competitively in visual discovery.

Valuation Debates: Investors express divided views on the stock's market cap near $15 billion, weighing AI-driven user growth against potential headwinds like advertising expenses and slowing momentum. Some describe it as a potential undervalued opportunity while others flag risks from competition. Overall, the tone reflects measured analysis of earnings implications.

Note: This discussion summary was generated from an AI condensation of post data.

Pinterest Insider Trading Activity

Pinterest insiders have traded $PINS stock on the open market 33 times in the past 6 months. Of those trades, 0 have been purchases and 33 have been sales.

Here’s a breakdown of recent trading of $PINS stock by insiders over the last 6 months:

BENJAMIN SILBERMANN has made 0 purchases and 23 sales selling 1,031,250 shares for an estimated $22,721,978.
DONNELLY JULIA BRAU (Chief Financial Officer) sold 59,096 shares for an estimated $1,387,715
WANJIKU JUANITA WALCOTT (Chief Legal & Bus Affairs Ofc.) has made 0 purchases and 2 sales selling 41,545 shares for an estimated $838,589.
CLAUDE LEONARD BROWN (Chief Business Officer) sold 12,240 shares for an estimated $292,285
GOKUL RAJARAM has made 0 purchases and 6 sales selling 7,350 shares for an estimated $154,066.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

Pinterest Revenue

Pinterest had revenues of $1.2B in Q2 2026. This is an increase of 18.17% from the same period in the prior year.

You can track PINS financials on Quiver Quantitative's PINS stock page.

You can access data on PINS stock through the Quiver Quantitative API.

Pinterest Congressional Stock Trading

Members of Congress have traded $PINS stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $PINS stock by members of Congress over the last 6 months:

REPRESENTATIVE CHRISTIAN MENEFEE has traded it 2 times. They made 0 purchases and 2 sales worth up to $100,000 on 08/07, 05/28.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

Pinterest Hedge Fund Activity

We have seen 307 institutional investors add shares of Pinterest stock to their portfolio, and 579 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

GOLDMAN SACHS GROUP INC removed 33,563,064 shares (-64.7%) from their portfolio in Q2 2026, for an estimated $705,831,235
AMERIPRISE FINANCIAL INC added 26,325,446 shares (+141.4%) to their portfolio in Q2 2026, for an estimated $553,624,129
BLACKROCK, INC. removed 16,709,928 shares (-26.1%) from their portfolio in Q2 2026, for an estimated $351,409,785
POINT72 ASSET MANAGEMENT, L.P. added 9,389,419 shares (+inf%) to their portfolio in Q2 2026, for an estimated $197,459,481
BALYASNY ASSET MANAGEMENT L.P. added 8,560,019 shares (+inf%) to their portfolio in Q2 2026, for an estimated $180,017,199
CITADEL ADVISORS LLC added 8,085,349 shares (+254.7%) to their portfolio in Q2 2026, for an estimated $170,034,889
UBS GROUP AG added 7,965,912 shares (+49.7%) to their portfolio in Q2 2026, for an estimated $167,523,129

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

Pinterest Analyst Ratings

Wall Street analysts have issued reports on $PINS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Benchmark issued a "Buy" rating on 04/30/2026

To track analyst ratings and price targets for Pinterest, check out Quiver Quantitative's $PINS forecast page.

Pinterest Price Targets

Multiple analysts have issued price targets for $PINS recently. We have seen 18 analysts offer price targets for $PINS in the last 6 months, with a median target of $27.0.

Here are some recent targets:

Wyatt Swanson from DA Davidson set a target price of $26.0 on 07/08/2026
Alec Brondolo from Wells Fargo set a target price of $30.0 on 07/07/2026
Michael Morris from Guggenheim set a target price of $24.0 on 06/15/2026
Brad Erickson from RBC Capital set a target price of $23.0 on 05/05/2026
Doug Anmuth from JP Morgan set a target price of $25.0 on 05/05/2026
John Blackledge from TD Cowen set a target price of $38.0 on 05/05/2026
Brian Nowak from Morgan Stanley set a target price of $30.0 on 05/05/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

BioVie Stock (BIVI) Opinions on Phase 2 Trial Results

21 hours ago | Aug. 29, 2026 5:33 p.m. UTC

Trial Results: Social media chatter around BioVie centers on the recent Phase 2 SUNRISE-PD trial data for its Parkinson's treatment, with observers noting the potential for the stock to push past key resistance levels if momentum builds.

Market Watch: Participants highlight unchanged fundamentals amid high short interest and an upcoming S-1 filing, while pointing to upcoming Phase 3 plans and long COVID data as key factors that could influence sentiment in the coming weeks.

Catalyst Focus: The overall tone reflects cautious optimism as investors track volume and follow-through after the clinical update, with some expressing interest in the biotech's next steps without committing to specific price targets.

Note: This discussion summary was generated from an AI condensation of post data.

BioVie Insider Trading Activity

BioVie insiders have traded $BIVI stock on the open market 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $BIVI stock by insiders over the last 6 months:

CUONG V DO (President & CEO) purchased 15,210 shares for an estimated $31,636
JOSEPH M PALUMBO (Chief Medical Officer) purchased 4,843 shares for an estimated $10,460
JOANNE WENDY KIM (Chief Financial Officer) purchased 2,500 shares for an estimated $5,450
AMY SUZON CHAPPELL purchased 727 shares for an estimated $1,570

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive BIVI Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

BioVie Hedge Fund Activity

We have seen 15 institutional investors add shares of BioVie stock to their portfolio, and 19 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

MORGAN STANLEY added 530,250 shares (+704.9%) to their portfolio in Q2 2026, for an estimated $1,028,685
DRW SECURITIES, LLC removed 128,356 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $179,698
DIAMETRIC CAPITAL, LP removed 113,364 shares (-30.6%) from their portfolio in Q2 2026, for an estimated $219,926
RENAISSANCE TECHNOLOGIES LLC added 60,000 shares (+88.3%) to their portfolio in Q2 2026, for an estimated $116,400
PRELUDE CAPITAL MANAGEMENT, LLC removed 59,480 shares (-64.6%) from their portfolio in Q2 2026, for an estimated $115,391
CITADEL ADVISORS LLC added 50,660 shares (+111.9%) to their portfolio in Q2 2026, for an estimated $98,280
PHILADELPHIA TRUST CO removed 25,000 shares (-33.3%) from their portfolio in Q2 2026, for an estimated $48,500

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

Innodata Stock (INOD) Opinions on Recent Earnings and Valuation

21 hours ago | Aug. 29, 2026 5:33 p.m. UTC

Valuation scrutiny intensifies: Social media chatter around Innodata has turned sharply critical following the company's latest quarterly results, with analysts highlighting how the stock's premium valuation appears to bake in years of flawless execution amid heavy customer concentration risks.

Earnings momentum examined: Observers noted solid revenue growth but flagged that much of the upside stemmed from a single large client expansion, raising questions about sustainability given the project-based nature of contracts and potential for abrupt cancellations.

Target price speculation emerges: A handful of posts referenced fresh analyst price targets, though sentiment remains tempered by concerns over management moves like an automatic shelf registration and leadership shifts that could signal upcoming capital raises.

Note: This discussion summary was generated from an AI condensation of post data.

Innodata Insider Trading Activity

Innodata insiders have traded $INOD stock on the open market 73 times in the past 6 months. Of those trades, 0 have been purchases and 73 have been sales.

Here’s a breakdown of recent trading of $INOD stock by insiders over the last 6 months:

JACK ABUHOFF (CEO) has made 0 purchases and 48 sales selling 1,233,651 shares for an estimated $121,919,007.
ASHOK MISHRA (EVP and COO) has made 0 purchases and 7 sales selling 281,567 shares for an estimated $26,318,564.
LOUISE C FORLENZA has made 0 purchases and 12 sales selling 68,000 shares for an estimated $6,181,555.
MARISSA B ESPINELI (Interim CFO) has made 0 purchases and 3 sales selling 19,667 shares for an estimated $2,082,435.
STEWART R MASSEY has made 0 purchases and 3 sales selling 20,000 shares for an estimated $1,842,180.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive INOD Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

Innodata Revenue

Innodata had revenues of $92.1M in Q2 2026. This is an increase of 57.8% from the same period in the prior year.

You can track INOD financials on Quiver Quantitative's INOD stock page.

You can access data on INOD stock through the Quiver Quantitative API.

Innodata Hedge Fund Activity

We have seen 164 institutional investors add shares of Innodata stock to their portfolio, and 159 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JANE STREET GROUP, LLC added 829,074 shares (+186.0%) to their portfolio in Q2 2026, for an estimated $62,661,412
JPMORGAN CHASE & CO added 479,084 shares (+inf%) to their portfolio in Q2 2026, for an estimated $36,209,168
WELLINGTON MANAGEMENT GROUP LLP removed 427,071 shares (-66.4%) from their portfolio in Q2 2026, for an estimated $32,278,026
DRIEHAUS CAPITAL MANAGEMENT LLC added 404,165 shares (+inf%) to their portfolio in Q2 2026, for an estimated $30,546,790
WESTFIELD CAPITAL MANAGEMENT CO LP added 375,091 shares (+inf%) to their portfolio in Q2 2026, for an estimated $28,349,377
BLACKROCK, INC. added 326,446 shares (+13.7%) to their portfolio in Q2 2026, for an estimated $24,672,788
RENAISSANCE TECHNOLOGIES LLC added 294,300 shares (+inf%) to their portfolio in Q2 2026, for an estimated $22,243,194

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

Innodata Analyst Ratings

Wall Street analysts have issued reports on $INOD in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

BWS Financial issued a "Top Pick" rating on 04/10/2026

To track analyst ratings and price targets for Innodata, check out Quiver Quantitative's $INOD forecast page.

Innodata Price Targets

Multiple analysts have issued price targets for $INOD recently. We have seen 2 analysts offer price targets for $INOD in the last 6 months, with a median target of $130.0.

Here are some recent targets:

Hamed Khorsand from BWS Financial set a target price of $140.0 on 06/15/2026
Dan Ives from Wedbush set a target price of $120.0 on 06/05/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

Natera Stock (NTRA) Opinions on Recent Price Surge

21 hours ago | Aug. 29, 2026 5:33 p.m. UTC

Stock Surges to Highs: Social media buzz centers on Natera's recent climb to fresh 52-week highs, with the shares trading near $340 after testing key moving averages. Observers highlight the stock's 80 percent gain since a recent support level, attributing momentum to broader healthcare sector strength.

Institutional Backing Noted: Discussions also reference major fund positions in the genetic testing firm, including a leading stake from Duquesne Capital as of mid-year. Participants point to solid revenue growth and improving margins from the latest quarterly update as factors sustaining interest.

Caution on Momentum: While the tone remains upbeat on the company's trajectory, some voices advise against chasing the current levels and suggest watching for pullbacks to reenter. Overall sentiment stays bullish amid the sector's outperformance.

Note: This discussion summary was generated from an AI condensation of post data.

Natera Insider Trading Activity

Natera insiders have traded $NTRA stock on the open market 264 times in the past 6 months. Of those trades, 0 have been purchases and 264 have been sales.

Here’s a breakdown of recent trading of $NTRA stock by insiders over the last 6 months:

MATTHEW RABINOWITZ (EXECUTIVE CHAIRMAN) has made 0 purchases and 53 sales selling 313,157 shares for an estimated $62,938,123.
DANIEL RABINOWITZ (SEC. AND CHIEF LEGAL OFFICER) has made 0 purchases and 33 sales selling 73,355 shares for an estimated $17,762,965.
ROELOF BOTHA has made 0 purchases and 6 sales selling 78,000 shares for an estimated $17,184,092.
STEVEN LEONARD CHAPMAN (CEO AND PRESIDENT) has made 0 purchases and 30 sales selling 66,283 shares for an estimated $14,704,918.
JONATHAN SHEENA has made 0 purchases and 75 sales selling 42,606 shares for an estimated $10,765,227.
SOLOMON MOSHKEVICH (PRESIDENT, CLINICALDIAGNOSTICS) has made 0 purchases and 33 sales selling 25,778 shares for an estimated $5,815,846.
HERM ROSENMAN sold 16,530 shares for an estimated $4,132,500
JOHN FESKO (PRESIDENT, CHIEF BUS. OFFICER) has made 0 purchases and 9 sales selling 12,649 shares for an estimated $3,455,226.
MICHAEL BURKES BROPHY (CHIEF FINANCIAL OFFICER) has made 0 purchases and 17 sales selling 12,502 shares for an estimated $2,826,537.
GAIL BOXER MARCUS has made 0 purchases and 4 sales selling 11,000 shares for an estimated $2,389,328.
ROWAN E CHAPMAN has made 0 purchases and 3 sales selling 3,221 shares for an estimated $702,984.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

Natera Revenue

Natera had revenues of $752.8M in Q2 2026. This is an increase of 37.71% from the same period in the prior year.

You can track NTRA financials on Quiver Quantitative's NTRA stock page.

You can access data on NTRA stock through the Quiver Quantitative API.

Natera Hedge Fund Activity

We have seen 502 institutional investors add shares of Natera stock to their portfolio, and 367 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JPMORGAN CHASE & CO added 12,865,346 shares (+inf%) to their portfolio in Q2 2026, for an estimated $3,492,298,171
PRICE T ROWE ASSOCIATES INC /MD/ removed 3,162,981 shares (-26.0%) from their portfolio in Q2 2026, for an estimated $858,591,192
FMR LLC added 2,897,142 shares (+113.4%) to their portfolio in Q2 2026, for an estimated $786,429,195
GOLDMAN SACHS GROUP INC added 952,921 shares (+124.2%) to their portfolio in Q2 2026, for an estimated $258,670,405
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 806,536 shares (+inf%) to their portfolio in Q2 2026, for an estimated $218,934,197
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 795,962 shares (+242.8%) to their portfolio in Q2 2026, for an estimated $216,063,884
WELLINGTON MANAGEMENT GROUP LLP removed 727,855 shares (-15.3%) from their portfolio in Q2 2026, for an estimated $197,576,239

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

Natera Government Contracts

We have seen $552,900 of award payments to $NTRA over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

TUMOR WHOLE EXOME SEQUENCING (WES) AND PERIPHERAL BLOOD CTDNA TEST TESTING (SINGLE ASSAY) SERVICES AND WES ...: $154,100
NEXT GENERATION SEQUENCING AND PERIPHERAL BLOOD CTDNA TESTING SERVICES (RESEARCH): $7,000
GENETIC TESTING: $3,300

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

Natera Analyst Ratings

Wall Street analysts have issued reports on $NTRA in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

BTIG issued a "Buy" rating on 06/23/2026
William Blair issued a "Outperform" rating on 04/14/2026

To track analyst ratings and price targets for Natera, check out Quiver Quantitative's $NTRA forecast page.

Natera Price Targets

Multiple analysts have issued price targets for $NTRA recently. We have seen 11 analysts offer price targets for $NTRA in the last 6 months, with a median target of $275.0.

Here are some recent targets:

Tejas Savant from Morgan Stanley set a target price of $310.0 on 07/09/2026
Daniel Markowitz from Evercore ISI Group set a target price of $300.0 on 07/06/2026
Subbu Nambi from Guggenheim set a target price of $290.0 on 06/29/2026
Eve Burstein from Bernstein set a target price of $310.0 on 06/26/2026
Luke Sergott from Barclays set a target price of $260.0 on 06/24/2026
Mark Massaro from BTIG set a target price of $275.0 on 06/24/2026
Dan Leonard from RBC Capital set a target price of $275.0 on 06/11/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

$ASTS stock fell 16% this week. Here's what we see in our data.

22 hours ago | Aug. 29, 2026 4:38 p.m. UTC

$ASTS stock fell 16% this week, according to our price data from Polygon.

It has been the 42nd most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $ASTS (you can track the company live on Quiver's $ASTS stock page):

$ASTS Insider Trading Activity

$ASTS insiders have traded $ASTS stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $ASTS stock by insiders over the last 6 months:

HIROSHI MIKITANI has made 0 purchases and 2 sales selling 3,040,000 shares for an estimated $270,896,800.
HUIWEN YAO (Chief Technology Officer) has made 0 purchases and 2 sales selling 80,000 shares for an estimated $7,410,000.
ANDREW MARTIN JOHNSON (CFO and CLO) has made 0 purchases and 2 sales selling 50,809 shares for an estimated $4,748,592.
JULIO A. TORRES sold 15,000 shares for an estimated $1,145,100

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$ASTS Hedge Fund Activity

We have seen 534 institutional investors add shares of $ASTS stock to their portfolio, and 267 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

RAKUTEN GROUP, INC. removed 15,510,077 shares (-50.0%) from their portfolio in Q2 2026, for an estimated $1,378,225,442
MORGAN STANLEY added 4,124,149 shares (+129.1%) to their portfolio in Q2 2026, for an estimated $366,471,880
JANE STREET GROUP, LLC added 3,559,370 shares (+14292.4%) to their portfolio in Q2 2026, for an estimated $316,285,618
UBS GROUP AG added 2,058,762 shares (+45.3%) to their portfolio in Q2 2026, for an estimated $182,941,591
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 1,640,466 shares (+inf%) to their portfolio in Q2 2026, for an estimated $145,771,808
GOLDMAN SACHS GROUP INC added 1,559,322 shares (+67.4%) to their portfolio in Q2 2026, for an estimated $138,561,352
FMR LLC removed 1,494,224 shares (-65.7%) from their portfolio in Q2 2026, for an estimated $132,776,744

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$ASTS Price Targets

Multiple analysts have issued price targets for $ASTS recently. We have seen 4 analysts offer price targets for $ASTS in the last 6 months, with a median target of $82.5.

Here are some recent targets:

Bryan Kraft from Deutsche Bank set a target price of $106.0 on 05/29/2026
Mike Crawford from B. Riley Securities set a target price of $85.0 on 05/12/2026
Christopher Schoell from UBS set a target price of $80.0 on 05/12/2026
Mathieu Robilliard from Barclays set a target price of $65.0 on 04/09/2026

You can track data on $ASTS on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

$AMAT stock fell 7% this week. Here's what we see in our data.

22 hours ago | Aug. 29, 2026 4:38 p.m. UTC

$AMAT stock fell 7% this week, according to our price data from Polygon.

It has been the 46th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $AMAT (you can track the company live on Quiver's $AMAT stock page):

$AMAT Insider Trading Activity

$AMAT insiders have traded $AMAT stock on the open market 35 times in the past 6 months. Of those trades, 0 have been purchases and 35 have been sales.

Here’s a breakdown of recent trading of $AMAT stock by insiders over the last 6 months:

GARY E DICKERSON (President and CEO) has made 0 purchases and 15 sales selling 161,321 shares for an estimated $104,789,403.
PRABU G. RAJA (President, Semi. Products Grp.) has made 0 purchases and 5 sales selling 60,000 shares for an estimated $31,599,496.
OMKARAM NALAMASU (Senior Vice President, CTO) has made 0 purchases and 9 sales selling 35,000 shares for an estimated $20,754,197.
THOMAS J IANNOTTI sold 9,250 shares for an estimated $5,547,872
TIMOTHY M DEANE (SVP, Applied Global Services) sold 8,621 shares for an estimated $5,092,984
BRICE HILL (SVP, CFO) has made 0 purchases and 2 sales selling 10,000 shares for an estimated $4,841,529.
JUDY BRUNER sold 1,128 shares for an estimated $507,600
ADAM SANDERS (Corp. Controller & CAO) sold 268 shares for an estimated $116,369

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$AMAT Hedge Fund Activity

We have seen 1,774 institutional investors add shares of $AMAT stock to their portfolio, and 1,530 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

INVESCO LTD. added 18,556,231 shares (+191.1%) to their portfolio in Q2 2026, for an estimated $13,416,155,013
JPMORGAN CHASE & CO added 13,886,053 shares (+inf%) to their portfolio in Q2 2026, for an estimated $10,039,616,319
CAPITAL RESEARCH GLOBAL INVESTORS removed 7,296,327 shares (-24.8%) from their portfolio in Q2 2026, for an estimated $5,275,244,421
PRICE T ROWE ASSOCIATES INC /MD/ added 6,564,630 shares (+108.3%) to their portfolio in Q2 2026, for an estimated $4,746,227,490
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 4,969,702 shares (+inf%) to their portfolio in Q2 2026, for an estimated $3,593,094,546
FMR LLC added 2,876,511 shares (+45.0%) to their portfolio in Q2 2026, for an estimated $2,079,717,453
AMERIPRISE FINANCIAL INC removed 2,544,655 shares (-28.5%) from their portfolio in Q2 2026, for an estimated $1,839,785,565

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$AMAT Congressional Stock Trading

Members of Congress have traded $AMAT stock 7 times in the past 6 months. Of those trades, 6 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $AMAT stock by members of Congress over the last 6 months:

REPRESENTATIVE JOHN MCGUIRE purchased up to $15,000 on 07/15.
REPRESENTATIVE JARED MOSKOWITZ has traded it 4 times. They made 4 purchases worth up to $60,000 on 07/13, 06/18 and 0 sales.
REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 07/10.
SENATOR ALAN ARMSTRONG purchased up to $50,000 on 03/27.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$AMAT Price Targets

Multiple analysts have issued price targets for $AMAT recently. We have seen 23 analysts offer price targets for $AMAT in the last 6 months, with a median target of $590.0.

Here are some recent targets:

Vijay Rakesh from Mizuho set a target price of $650.0 on 07/09/2026
Krish Sankar from TD Cowen set a target price of $700.0 on 07/09/2026
Shane Brett from Morgan Stanley set a target price of $647.0 on 07/06/2026
Mehdi Hosseini from Susquehanna set a target price of $900.0 on 06/30/2026
C.J. Muse from Cantor Fitzgerald set a target price of $850.0 on 06/29/2026
Steve Barger from Keybanc set a target price of $750.0 on 06/29/2026
Craig Ellis from B. Riley Securities set a target price of $790.0 on 06/26/2026

You can track data on $AMAT on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

$NBIS stock fell 5% this week. Here's what we see in our data.

22 hours ago | Aug. 29, 2026 4:38 p.m. UTC

$NBIS stock fell 5% this week, according to our price data from Polygon.

It has been the 44th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $NBIS (you can track the company live on Quiver's $NBIS stock page):

$NBIS Insider Trading Activity

$NBIS insiders have traded $NBIS stock on the open market 64 times in the past 6 months. Of those trades, 0 have been purchases and 64 have been sales.

Here’s a breakdown of recent trading of $NBIS stock by insiders over the last 6 months:

ANDREY KOROLENKO (Chief Infrastructure Officer) has made 0 purchases and 4 sales selling 592,204 shares for an estimated $115,746,396.
ARKADIY VOLOZH (CEO) has made 0 purchases and 2 sales selling 79,985 shares for an estimated $14,438,599.
CHARLES E RYAN has made 0 purchases and 6 sales selling 50,000 shares for an estimated $13,276,633.
DANILA SHTAN (Chief Technology Officer) has made 0 purchases and 3 sales selling 46,104 shares for an estimated $9,066,645.
ELENA BUNINA has made 0 purchases and 8 sales selling 47,655 shares for an estimated $8,261,325.
MARC BORODITSKY (Chief Revenue Officer) has made 0 purchases and 3 sales selling 19,776 shares for an estimated $4,675,758.
JOHN WILSON IV BOYNTON has made 0 purchases and 33 sales selling 18,066 shares for an estimated $4,277,984.
BOAZ TAL (General Counsel) has made 0 purchases and 4 sales selling 8,136 shares for an estimated $1,316,786.
SANCHEZ MARIA DEL DADO ALONSO (CFO) sold 1,509 shares for an estimated $416,786

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$NBIS Hedge Fund Activity

We have seen 687 institutional investors add shares of $NBIS stock to their portfolio, and 386 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

GOLDMAN SACHS GROUP INC added 6,715,646 shares (+217.8%) to their portfolio in Q2 2026, for an estimated $1,854,659,955
INVESCO LTD. added 5,178,910 shares (+293.5%) to their portfolio in Q2 2026, for an estimated $1,430,259,574
BANK OF AMERICA CORP /DE/ added 4,639,882 shares (+309.6%) to their portfolio in Q2 2026, for an estimated $1,281,396,211
LONE PINE CAPITAL LLC added 4,258,008 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,175,934,069
JPMORGAN CHASE & CO added 3,995,496 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,103,436,130
FRED ALGER MANAGEMENT, LLC removed 3,872,749 shares (-40.3%) from their portfolio in Q2 2026, for an estimated $1,069,537,091
CAPITAL RESEARCH GLOBAL INVESTORS removed 3,359,169 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $927,701,702

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$NBIS Congressional Stock Trading

Members of Congress have traded $NBIS stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $NBIS stock by members of Congress over the last 6 months:

SENATOR ALAN ARMSTRONG purchased up to $15,000 on 03/30.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$NBIS Price Targets

Multiple analysts have issued price targets for $NBIS recently. We have seen 9 analysts offer price targets for $NBIS in the last 6 months, with a median target of $250.0.

Here are some recent targets:

Tal Liani from B of A Securities set a target price of $280.0 on 06/08/2026
Stefan Slowinski from BNP Paribas set a target price of $255.0 on 06/02/2026
Gil Luria from DA Davidson set a target price of $250.0 on 05/18/2026
Tyler Radke from Citigroup set a target price of $287.0 on 05/15/2026
Greg P. Miller from Citizens set a target price of $270.0 on 05/14/2026
Josh Baer from Morgan Stanley set a target price of $144.0 on 05/14/2026
Brett Knoblauch from Cantor Fitzgerald set a target price of $129.0 on 04/09/2026

You can track data on $NBIS on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

$SNDK stock fell 7% this week. Here's what we see in our data.

22 hours ago | Aug. 29, 2026 4:38 p.m. UTC

$SNDK stock fell 7% this week, according to our price data from Polygon.

It has been the 43rd most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $SNDK (you can track the company live on Quiver's $SNDK stock page):

$SNDK Insider Trading Activity

$SNDK insiders have traded $SNDK stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $SNDK stock by insiders over the last 6 months:

ALPER ILKBAHAR (EVP, Chief Technology Officer) has made 0 purchases and 3 sales selling 2,000 shares for an estimated $3,513,152.
MICHAEL POKORNY (VP, Chief Accounting Officer) sold 2,446 shares for an estimated $3,488,436
BERNARD SHEK (Chief Legal Officer & Secty) has made 0 purchases and 3 sales selling 1,800 shares for an estimated $2,991,696.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$SNDK Hedge Fund Activity

We have seen 1,241 institutional investors add shares of $SNDK stock to their portfolio, and 573 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FMR LLC removed 5,528,320 shares (-41.3%) from their portfolio in Q2 2026, for an estimated $12,569,907,033
INVESCO LTD. added 4,445,122 shares (+381.5%) to their portfolio in Q2 2026, for an estimated $10,107,007,245
JPMORGAN CHASE & CO added 3,941,436 shares (+inf%) to their portfolio in Q2 2026, for an estimated $8,961,761,276
CLEAR STREET GROUP INC. added 1,758,809 shares (+143.6%) to their portfolio in Q2 2026, for an estimated $3,999,056,787
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 1,741,577 shares (+inf%) to their portfolio in Q2 2026, for an estimated $3,959,875,872
D. E. SHAW & CO., INC. removed 1,531,092 shares (-73.2%) from their portfolio in Q2 2026, for an estimated $3,481,289,813
RENAISSANCE TECHNOLOGIES LLC removed 794,588 shares (-99.4%) from their portfolio in Q2 2026, for an estimated $1,806,678,573

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

EARLY ACCESS

Receive SNDK Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$SNDK Congressional Stock Trading

Members of Congress have traded $SNDK stock 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $SNDK stock by members of Congress over the last 6 months:

REPRESENTATIVE JOSH GOTTHEIMER purchased up to $15,000 on 05/07.
SENATOR ALAN ARMSTRONG purchased up to $15,000 on 03/27.
REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 03/13.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$SNDK Analyst Ratings

Wall Street analysts have issued reports on $SNDK in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Susquehanna issued a "Positive" rating on 05/01/2026
KGI Securities issued a "Outperform" rating on 03/18/2026

To track analyst ratings and price targets for $SNDK, check out Quiver Quantitative's $SNDK forecast page.

$SNDK Price Targets

Multiple analysts have issued price targets for $SNDK recently. We have seen 14 analysts offer price targets for $SNDK in the last 6 months, with a median target of $2000.0.

Here are some recent targets:

Wamsi Mohan from B of A Securities set a target price of $2500.0 on 07/01/2026
Mark C. Newman from Bernstein set a target price of $3000.0 on 06/30/2026
Asiya Merchant from Citigroup set a target price of $2500.0 on 06/25/2026
C.J. Muse from Cantor Fitzgerald set a target price of $2900.0 on 06/08/2026
Vijay Rakesh from Mizuho set a target price of $2200.0 on 06/08/2026
Joseph Moore from Morgan Stanley set a target price of $1750.0 on 06/03/2026
Mehdi Hosseini from Susquehanna set a target price of $3250.0 on 05/29/2026

You can track data on $SNDK on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

$RXRX stock fell 5% this week. Here's what we see in our data.

22 hours ago | Aug. 29, 2026 4:38 p.m. UTC

$RXRX stock fell 5% this week, according to our price data from Polygon.

It has been the 47th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $RXRX (you can track the company live on Quiver's $RXRX stock page):

$RXRX Insider Trading Activity

$RXRX insiders have traded $RXRX stock on the open market 16 times in the past 6 months. Of those trades, 0 have been purchases and 16 have been sales.

Here’s a breakdown of recent trading of $RXRX stock by insiders over the last 6 months:

BLAKE BORGESON has made 0 purchases and 6 sales selling 330,000 shares for an estimated $1,153,200.
CHRISTOPHER GIBSON has made 0 purchases and 5 sales selling 200,000 shares for an estimated $666,400.
NAJAT KHAN (CEO and President) has made 0 purchases and 2 sales selling 51,886 shares for an estimated $179,118.
NAMANDJE BUMPUS has made 0 purchases and 2 sales selling 8,349 shares for an estimated $28,128.
BEN R TAYLOR (Chief Financial Officer) sold 7,956 shares for an estimated $26,970

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$RXRX Hedge Fund Activity

We have seen 177 institutional investors add shares of $RXRX stock to their portfolio, and 176 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

NOVO HOLDINGS A/S removed 7,929,835 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $24,344,593
BLACKROCK, INC. added 7,112,385 shares (+16.5%) to their portfolio in Q2 2026, for an estimated $26,102,452
STATE STREET CORP added 6,215,492 shares (+21.8%) to their portfolio in Q2 2026, for an estimated $22,810,855
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 4,138,286 shares (+inf%) to their portfolio in Q2 2026, for an estimated $15,187,509
UBS GROUP AG added 3,845,865 shares (+75.4%) to their portfolio in Q2 2026, for an estimated $14,114,324
LINGOTTO INVESTMENT MANAGEMENT LLP removed 3,675,077 shares (-62.5%) from their portfolio in Q2 2026, for an estimated $13,487,532
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 3,263,269 shares (-81.1%) from their portfolio in Q2 2026, for an estimated $11,976,197

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$RXRX Price Targets

Multiple analysts have issued price targets for $RXRX recently. We have seen 3 analysts offer price targets for $RXRX in the last 6 months, with a median target of $8.0.

Here are some recent targets:

Vikram Purohit from Morgan Stanley set a target price of $5.5 on 05/14/2026
Gil Blum from Needham set a target price of $8.0 on 05/07/2026
Priyanka Grover from JP Morgan set a target price of $10.0 on 04/30/2026

You can track data on $RXRX on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

$TEM stock fell 12% this week. Here's what we see in our data.

22 hours ago | Aug. 29, 2026 4:38 p.m. UTC

$TEM stock fell 12% this week, according to our price data from Polygon.

It has been the 7th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $TEM (you can track the company live on Quiver's $TEM stock page):

$TEM Insider Trading Activity

$TEM insiders have traded $TEM stock on the open market 103 times in the past 6 months. Of those trades, 0 have been purchases and 103 have been sales.

Here’s a breakdown of recent trading of $TEM stock by insiders over the last 6 months:

ERIC P LEFKOFSKY (CEO and Chairman) has made 0 purchases and 70 sales selling 1,319,926 shares for an estimated $68,723,000.
RYAN FUKUSHIMA (CEO, Data) has made 0 purchases and 13 sales selling 141,747 shares for an estimated $7,246,870.
JAMES WILLIAM ROGERS (Chief Financial Officer) has made 0 purchases and 4 sales selling 71,224 shares for an estimated $3,808,830.
ANDREW POLOVIN (EVP, Chief Legal Officer) has made 0 purchases and 3 sales selling 38,778 shares for an estimated $1,926,215.
THOMAS EDWARD SCHOENHERR (CEO, Diagnostics) has made 0 purchases and 8 sales selling 18,894 shares for an estimated $999,621.
RYAN M BARTOLUCCI (Chief Accounting Officer) has made 0 purchases and 2 sales selling 10,291 shares for an estimated $487,733.
JENNIFER A DOUDNA sold 2,673 shares for an estimated $147,015
DAVID R EPSTEIN has made 0 purchases and 2 sales selling 620 shares for an estimated $28,408.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$TEM Hedge Fund Activity

We have seen 281 institutional investors add shares of $TEM stock to their portfolio, and 243 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JPMORGAN CHASE & CO added 4,989,062 shares (+inf%) to their portfolio in Q2 2026, for an estimated $289,016,361
GC WEALTH MANAGEMENT RIA, LLC removed 4,199,843 shares (-63.5%) from their portfolio in Q2 2026, for an estimated $243,296,904
GOLDMAN SACHS GROUP INC added 2,483,910 shares (+194.4%) to their portfolio in Q2 2026, for an estimated $143,892,906
CITADEL ADVISORS LLC added 1,911,096 shares (+317.8%) to their portfolio in Q2 2026, for an estimated $110,709,791
MORGAN STANLEY added 1,568,701 shares (+75.3%) to their portfolio in Q2 2026, for an estimated $90,874,848
BANK OF AMERICA CORP /DE/ added 1,502,992 shares (+362.4%) to their portfolio in Q2 2026, for an estimated $87,068,326
D. E. SHAW & CO., INC. removed 1,180,315 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $68,375,647

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

EARLY ACCESS

Receive TEM Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$TEM Government Contracts

We have seen $29,358,042 of award payments to $TEM over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

ADAPT CRO SUPPORT SERVICES SOLICITATION: $12,741,975

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

$TEM Price Targets

Multiple analysts have issued price targets for $TEM recently. We have seen 8 analysts offer price targets for $TEM in the last 6 months, with a median target of $66.0.

Here are some recent targets:

Gene Mannheimer from Freedom Capital Markets set a target price of $59.0 on 07/01/2026
Ryan MacDonald from Needham set a target price of $75.0 on 06/01/2026
Mark Massaro from BTIG set a target price of $80.0 on 06/01/2026
Yi Chen from HC Wainwright & Co. set a target price of $64.0 on 05/11/2026
Dan Brennan from TD Cowen set a target price of $68.0 on 05/06/2026
Tycho Peterson from Jefferies set a target price of $35.0 on 04/13/2026
Subbu Nambi from Guggenheim set a target price of $60.0 on 03/30/2026

You can track data on $TEM on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

$RGTI stock fell 13% this week. Here's what we see in our data.

22 hours ago | Aug. 29, 2026 4:38 p.m. UTC

$RGTI stock fell 13% this week, according to our price data from Polygon.

It has been the 34th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $RGTI (you can track the company live on Quiver's $RGTI stock page):

$RGTI Insider Trading Activity

$RGTI insiders have traded $RGTI stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.

Here’s a breakdown of recent trading of $RGTI stock by insiders over the last 6 months:

DAVID RIVAS (CHIEF OPERATING OFFICER) has made 0 purchases and 4 sales selling 527,125 shares for an estimated $13,263,310.
RAY O JOHNSON has made 0 purchases and 3 sales selling 207,132 shares for an estimated $4,348,083.
SUBODH K KULKARNI (President and CEO) has made 0 purchases and 2 sales selling 104,190 shares for an estimated $2,619,903.
JEFFREY A. BERTELSEN (CHIEF FINANCIAL OFFICER) has made 0 purchases and 3 sales selling 7,542 shares for an estimated $149,675.
ANDREW JOSEPH BESTWICK (CHIEF TECHNOLOGY OFFICER) sold 5,791 shares for an estimated $97,319

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$RGTI Hedge Fund Activity

We have seen 299 institutional investors add shares of $RGTI stock to their portfolio, and 217 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

HRT FINANCIAL LP removed 3,515,852 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $67,926,260
BLACKROCK, INC. added 3,098,204 shares (+12.2%) to their portfolio in Q2 2026, for an estimated $59,857,301
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 2,842,839 shares (+inf%) to their portfolio in Q2 2026, for an estimated $54,923,649
TWO SIGMA INVESTMENTS, LP removed 2,478,635 shares (-89.0%) from their portfolio in Q2 2026, for an estimated $47,887,228
ALYESKA INVESTMENT GROUP, L.P. removed 1,990,719 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $38,460,691
RENAISSANCE TECHNOLOGIES LLC removed 1,846,451 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $25,924,172
D. E. SHAW & CO., INC. added 1,844,653 shares (+52.4%) to their portfolio in Q2 2026, for an estimated $35,638,695

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$RGTI Price Targets

Multiple analysts have issued price targets for $RGTI recently. We have seen 4 analysts offer price targets for $RGTI in the last 6 months, with a median target of $29.0.

Here are some recent targets:

John McPeake from Rosenblatt set a target price of $40.0 on 06/11/2026
N. Quinn Bolton from Needham set a target price of $31.0 on 05/12/2026
Vijay Rakesh from Mizuho set a target price of $27.0 on 05/12/2026
David Williams from Benchmark set a target price of $25.0 on 03/20/2026

You can track data on $RGTI on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

$OPEN stock fell 7% this week. Here's what we see in our data.

22 hours ago | Aug. 29, 2026 4:38 p.m. UTC

$OPEN stock fell 7% this week, according to our price data from Polygon.

It has been the 28th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $OPEN (you can track the company live on Quiver's $OPEN stock page):

$OPEN Insider Trading Activity

$OPEN insiders have traded $OPEN stock on the open market 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $OPEN stock by insiders over the last 6 months:

DAVID C BENSON sold 40,000 shares for an estimated $193,364
KASRA NEJATIAN (Chief Executive Officer) purchased 27,625 shares for an estimated $100,002
GIANG NGUYEN (Chief Operating Officer) has made 0 purchases and 2 sales selling 14,457 shares for an estimated $67,311.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$OPEN Hedge Fund Activity

We have seen 217 institutional investors add shares of $OPEN stock to their portfolio, and 195 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

BLACKROCK, INC. added 54,285,537 shares (+291.3%) to their portfolio in Q2 2026, for an estimated $250,799,180
STATE STREET CORP added 15,790,615 shares (+264.2%) to their portfolio in Q2 2026, for an estimated $72,952,641
JANE STREET GROUP, LLC removed 14,621,933 shares (-99.4%) from their portfolio in Q2 2026, for an estimated $67,553,330
GEODE CAPITAL MANAGEMENT, LLC added 12,620,673 shares (+102.3%) to their portfolio in Q2 2026, for an estimated $58,307,509
MORGAN STANLEY added 12,430,422 shares (+12.1%) to their portfolio in Q2 2026, for an estimated $57,428,549
MILLENNIUM MANAGEMENT LLC removed 10,718,272 shares (-98.9%) from their portfolio in Q2 2026, for an estimated $49,518,416
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 10,290,223 shares (+inf%) to their portfolio in Q2 2026, for an estimated $47,540,830

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

EARLY ACCESS

Receive OPEN Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

You can track data on $OPEN on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

$IR stock fell 3% this week. Here's what we see in our data.

22 hours ago | Aug. 29, 2026 4:38 p.m. UTC

$IR stock fell 3% this week, according to our price data from Polygon.

It has been the 10th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $IR (you can track the company live on Quiver's $IR stock page):

$IR Insider Trading Activity

$IR insiders have traded $IR stock on the open market 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $IR stock by insiders over the last 6 months:

VICENTE REYNAL (See Remarks) has made 0 purchases and 2 sales selling 148,536 shares for an estimated $13,792,416.
AUROBIND SATPATHY purchased 11,538 shares for an estimated $1,000,090

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$IR Hedge Fund Activity

We have seen 359 institutional investors add shares of $IR stock to their portfolio, and 532 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JPMORGAN CHASE & CO added 10,642,725 shares (+inf%) to their portfolio in Q2 2026, for an estimated $872,597,022
FMR LLC removed 7,717,232 shares (-36.8%) from their portfolio in Q2 2026, for an estimated $632,735,851
PRICE T ROWE ASSOCIATES INC /MD/ added 6,700,975 shares (+33.0%) to their portfolio in Q2 2026, for an estimated $549,412,940
CAPITAL RESEARCH GLOBAL INVESTORS removed 4,254,750 shares (-14.4%) from their portfolio in Q2 2026, for an estimated $348,846,952
NORDEA INVESTMENT MANAGEMENT AB added 3,778,052 shares (+225.2%) to their portfolio in Q2 2026, for an estimated $309,762,483
CAPITAL WORLD INVESTORS removed 3,302,666 shares (-10.6%) from their portfolio in Q2 2026, for an estimated $270,785,585
CAPITAL INTERNATIONAL INVESTORS removed 3,260,215 shares (-24.7%) from their portfolio in Q2 2026, for an estimated $267,305,027

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

EARLY ACCESS

Receive IR Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$IR Analyst Ratings

Wall Street analysts have issued reports on $IR in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Barclays issued a "Overweight" rating on 04/30/2026

To track analyst ratings and price targets for $IR, check out Quiver Quantitative's $IR forecast page.

$IR Price Targets

Multiple analysts have issued price targets for $IR recently. We have seen 5 analysts offer price targets for $IR in the last 6 months, with a median target of $90.0.

Here are some recent targets:

Chris Snyder from Morgan Stanley set a target price of $80.0 on 06/03/2026
Joseph O'Dea from Wells Fargo set a target price of $88.0 on 04/30/2026
Julian Mitchell from Barclays set a target price of $95.0 on 04/30/2026
Andrew Kaplowitz from Citigroup set a target price of $109.0 on 04/30/2026
Nathan Jones from Stifel set a target price of $90.0 on 04/14/2026

You can track data on $IR on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

$CRWV stock fell 5% this week. Here's what we see in our data.

22 hours ago | Aug. 29, 2026 4:38 p.m. UTC

$CRWV stock fell 5% this week, according to our price data from Polygon.

It has been the 19th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $CRWV (you can track the company live on Quiver's $CRWV stock page):

$CRWV Insider Trading Activity

$CRWV insiders have traded $CRWV stock on the open market 2160 times in the past 6 months. Of those trades, 0 have been purchases and 2160 have been sales.

Here’s a breakdown of recent trading of $CRWV stock by insiders over the last 6 months:

FINANCIAL LLC MAGNETAR has made 0 purchases and 473 sales selling 17,136,910 shares for an estimated $2,030,187,822.
BRIAN M VENTURO (Chief Strategy Officer) has made 0 purchases and 302 sales selling 7,944,081 shares for an estimated $788,283,838.
MICHAEL N INTRATOR (CEO and President) has made 0 purchases and 353 sales selling 7,069,728 shares for an estimated $689,412,489.
BRANNIN MCBEE (Chief Development Officer) has made 0 purchases and 887 sales selling 5,120,031 shares for an estimated $466,786,950.
JACK D COGEN has made 0 purchases and 29 sales selling 2,000,000 shares for an estimated $214,019,236.
NITIN AGRAWAL (Chief Financial Officer) has made 0 purchases and 43 sales selling 324,086 shares for an estimated $29,799,107.
CHEN GOLDBERG (EVP, Product & Engineering) has made 0 purchases and 31 sales selling 94,217 shares for an estimated $9,669,816.
JEFF BAKER (Principal Accounting Officer) has made 0 purchases and 10 sales selling 62,826 shares for an estimated $6,586,367.
SACHIN JAIN (Chief Operating Officer) has made 0 purchases and 11 sales selling 46,265 shares for an estimated $4,635,296.
KAREN BOONE has made 0 purchases and 4 sales selling 11,580 shares for an estimated $1,245,045.
KRISTEN J MCVEETY (GC and Secretary) has made 0 purchases and 17 sales selling 12,196 shares for an estimated $1,165,026.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$CRWV Hedge Fund Activity

We have seen 673 institutional investors add shares of $CRWV stock to their portfolio, and 342 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

MAGNETAR FINANCIAL LLC removed 16,503,467 shares (-24.1%) from their portfolio in Q2 2026, for an estimated $1,642,755,105
BLACKROCK, INC. added 14,727,734 shares (+157.0%) to their portfolio in Q2 2026, for an estimated $1,465,998,642
INVESCO LTD. added 11,415,570 shares (+1149.5%) to their portfolio in Q2 2026, for an estimated $1,136,305,837
JANE STREET GROUP, LLC added 5,028,333 shares (+56.8%) to their portfolio in Q2 2026, for an estimated $500,520,266
NORGES BANK added 4,320,898 shares (+inf%) to their portfolio in Q2 2026, for an estimated $430,102,186
STATE STREET CORP added 4,113,873 shares (+139.7%) to their portfolio in Q2 2026, for an estimated $409,494,918
ALYESKA INVESTMENT GROUP, L.P. added 3,897,741 shares (+55.7%) to their portfolio in Q2 2026, for an estimated $387,981,139

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$CRWV Analyst Ratings

Wall Street analysts have issued reports on $CRWV in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

BNP Paribas issued a "Outperform" rating on 06/02/2026

To track analyst ratings and price targets for $CRWV, check out Quiver Quantitative's $CRWV forecast page.

$CRWV Price Targets

Multiple analysts have issued price targets for $CRWV recently. We have seen 18 analysts offer price targets for $CRWV in the last 6 months, with a median target of $145.0.

Here are some recent targets:

John McPeake from Rosenblatt set a target price of $250.0 on 07/02/2026
Brett Knoblauch from Cantor Fitzgerald set a target price of $167.0 on 06/16/2026
Stefan Slowinski from BNP Paribas set a target price of $192.0 on 06/02/2026
Gil Luria from DA Davidson set a target price of $100.0 on 05/18/2026
Tyler Radke from Citigroup set a target price of $158.0 on 05/14/2026
Raimo Lenschow from Barclays set a target price of $120.0 on 05/11/2026
Gregg Moskowitz from Mizuho set a target price of $110.0 on 05/08/2026

You can track data on $CRWV on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

$RKLB stock fell 12% this week. Here's what we see in our data.

22 hours ago | Aug. 29, 2026 4:38 p.m. UTC

$RKLB stock fell 12% this week, according to our price data from Polygon.

It has been the 27th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $RKLB (you can track the company live on Quiver's $RKLB stock page):

$RKLB Insider Trading Activity

$RKLB insiders have traded $RKLB stock on the open market 126 times in the past 6 months. Of those trades, 0 have been purchases and 126 have been sales.

Here’s a breakdown of recent trading of $RKLB stock by insiders over the last 6 months:

PETER BECK (CEO) has made 0 purchases and 29 sales selling 3,294,636 shares for an estimated $287,722,452.
ARJUN KAMPANI (SVP & General Counsel) has made 0 purchases and 32 sales selling 276,732 shares for an estimated $31,907,294.
ALEXANDER R SLUSKY has made 0 purchases and 7 sales selling 200,000 shares for an estimated $25,715,726.
FRANK KLEIN (Chief Operations Officer) has made 0 purchases and 30 sales selling 243,750 shares for an estimated $23,053,572.
ADAM C. SPICE (Chief Financial Officer) has made 0 purchases and 14 sales selling 135,165 shares for an estimated $13,985,771.
MARVIN BRADFORD CLEVENGER (President, Rocket Lab USA, Inc) has made 0 purchases and 10 sales selling 34,100 shares for an estimated $3,778,202.
MERLINE SAINTIL sold 18,126 shares for an estimated $1,360,171
AGOSTINO RICUPATI (VP Corp Controller & CAO) has made 0 purchases and 3 sales selling 669 shares for an estimated $46,581.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$RKLB Hedge Fund Activity

We have seen 787 institutional investors add shares of $RKLB stock to their portfolio, and 364 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

INVESCO LTD. added 14,745,237 shares (+409.8%) to their portfolio in Q2 2026, for an estimated $1,498,853,341
JPMORGAN CHASE & CO added 13,805,113 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,403,289,736
BAILLIE GIFFORD & CO removed 7,466,934 shares (-41.8%) from their portfolio in Q2 2026, for an estimated $759,013,841
CAPITAL INTERNATIONAL INVESTORS removed 6,694,910 shares (-99.9%) from their portfolio in Q2 2026, for an estimated $680,537,601
D. E. SHAW & CO., INC. removed 5,541,183 shares (-83.4%) from their portfolio in Q2 2026, for an estimated $563,261,251
DEFIANCE ETFS, LLC removed 5,055,612 shares (-89.9%) from their portfolio in Q2 2026, for an estimated $513,902,959
GOLDMAN SACHS GROUP INC added 3,003,173 shares (+117.5%) to their portfolio in Q2 2026, for an estimated $305,272,535

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$RKLB Government Contracts

We have seen $24,793,081 of award payments to $RKLB over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

$RKLB Price Targets

Multiple analysts have issued price targets for $RKLB recently. We have seen 13 analysts offer price targets for $RKLB in the last 6 months, with a median target of $120.0.

Here are some recent targets:

Ryan Koontz from Needham set a target price of $120.0 on 06/30/2026
Trevor Walsh from Citizens set a target price of $130.0 on 06/30/2026
Suji Desilva from Roth Capital set a target price of $130.0 on 06/30/2026
Jeff Van Rhee from Craig-Hallum set a target price of $120.0 on 06/30/2026
Ronald Epstein from B of A Securities set a target price of $115.0 on 06/30/2026
Andres Sheppard from Cantor Fitzgerald set a target price of $96.0 on 06/30/2026
Michael Leshock from Keybanc set a target price of $135.0 on 06/15/2026

You can track data on $RKLB on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

$CBRS stock fell 9% this week. Here's what we see in our data.

22 hours ago | Aug. 29, 2026 4:38 p.m. UTC

$CBRS stock fell 9% this week, according to our price data from Polygon.

It has been the 41st most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $CBRS (you can track the company live on Quiver's $CBRS stock page):

$CBRS Insider Trading Activity

$CBRS insiders have traded $CBRS stock on the open market 268 times in the past 6 months. Of those trades, 0 have been purchases and 268 have been sales.

Here’s a breakdown of recent trading of $CBRS stock by insiders over the last 6 months:

SEAN LIE (Chief Technology Officer) has made 0 purchases and 53 sales selling 757,830 shares for an estimated $157,480,539.
ANDREW D. FELDMAN (CEO, President) has made 0 purchases and 51 sales selling 282,193 shares for an estimated $56,373,054.
DHIRAJ MALLICK (Chief Operating Officer) has made 0 purchases and 84 sales selling 118,334 shares for an estimated $22,759,553.
ERIC VISHRIA has made 0 purchases and 6 sales selling 68,268 shares for an estimated $15,685,957.
STEVEN VASSALLO has made 0 purchases and 5 sales selling 50,000 shares for an estimated $10,909,101.
YAGNESH PATEL (Chief Accounting Officer) has made 0 purchases and 69 sales selling 14,653 shares for an estimated $2,755,958.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$CBRS Hedge Fund Activity

We have seen 387 institutional investors add shares of $CBRS stock to their portfolio, and 0 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

ECLIPSE OPERATIONS, LLC added 11,446,270 shares (+inf%) to their portfolio in Q2 2026, for an estimated $2,529,625,670
FMR LLC added 8,435,095 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,864,155,995
COATUE MANAGEMENT LLC added 7,011,028 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,549,437,188
CAPITAL WORLD INVESTORS added 3,894,458 shares (+inf%) to their portfolio in Q2 2026, for an estimated $860,675,218
MORGAN STANLEY added 3,224,209 shares (+inf%) to their portfolio in Q2 2026, for an estimated $712,550,189
ATREIDES MANAGEMENT, LP added 3,110,086 shares (+inf%) to their portfolio in Q2 2026, for an estimated $687,329,006
JPMORGAN CHASE & CO added 3,100,806 shares (+inf%) to their portfolio in Q2 2026, for an estimated $685,278,126

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

EARLY ACCESS

Receive CBRS Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$CBRS Analyst Ratings

Wall Street analysts have issued reports on $CBRS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Needham issued a "Buy" rating on 06/08/2026

To track analyst ratings and price targets for $CBRS, check out Quiver Quantitative's $CBRS forecast page.

$CBRS Price Targets

Multiple analysts have issued price targets for $CBRS recently. We have seen 11 analysts offer price targets for $CBRS in the last 6 months, with a median target of $300.0.

Here are some recent targets:

Paul Meeks from Freedom Capital Markets set a target price of $209.0 on 06/30/2026
N. Quinn Bolton from Needham set a target price of $300.0 on 06/24/2026
Matt Bryson from Wedbush set a target price of $280.0 on 06/24/2026
Joseph Moore from Morgan Stanley set a target price of $273.0 on 06/24/2026
Kevin Cassidy from Rosenblatt set a target price of $300.0 on 06/24/2026
Timothy Arcuri from UBS set a target price of $320.0 on 06/24/2026
Richard Shannon from Craig-Hallum set a target price of $325.0 on 06/09/2026

You can track data on $CBRS on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

$ONDS stock fell 10% this week. Here's what we see in our data.

22 hours ago | Aug. 29, 2026 4:38 p.m. UTC

$ONDS stock fell 10% this week, according to our price data from Polygon.

It has been the 31st most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $ONDS (you can track the company live on Quiver's $ONDS stock page):

$ONDS Insider Trading Activity

$ONDS insiders have traded $ONDS stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $ONDS stock by insiders over the last 6 months:

ERIC A BROCK (Chairman, CEO and President) sold 2,378,245 shares for an estimated $31,939,830
RICHARD M COHEN has made 0 purchases and 2 sales selling 15,000 shares for an estimated $138,426.
RANDY SEIDL sold 10,000 shares for an estimated $98,300

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$ONDS Hedge Fund Activity

We have seen 300 institutional investors add shares of $ONDS stock to their portfolio, and 193 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

BLACKROCK, INC. added 30,188,317 shares (+324.2%) to their portfolio in Q2 2026, for an estimated $248,751,732
STATE STREET CORP added 9,156,487 shares (+142.6%) to their portfolio in Q2 2026, for an estimated $75,449,452
DEFIANCE ETFS, LLC removed 9,063,375 shares (-87.6%) from their portfolio in Q2 2026, for an estimated $74,682,210
GEODE CAPITAL MANAGEMENT, LLC added 7,414,164 shares (+139.9%) to their portfolio in Q2 2026, for an estimated $61,092,711
JPMORGAN CHASE & CO added 6,593,434 shares (+inf%) to their portfolio in Q2 2026, for an estimated $54,329,896
HRT FINANCIAL LP removed 6,210,148 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $56,139,737
MILLENNIUM MANAGEMENT LLC removed 5,616,989 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $46,283,989

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$ONDS Analyst Ratings

Wall Street analysts have issued reports on $ONDS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Needham issued a "Buy" rating on 03/24/2026

To track analyst ratings and price targets for $ONDS, check out Quiver Quantitative's $ONDS forecast page.

$ONDS Price Targets

Multiple analysts have issued price targets for $ONDS recently. We have seen 2 analysts offer price targets for $ONDS in the last 6 months, with a median target of $18.5.

Here are some recent targets:

Austin Bohlig from Needham set a target price of $19.0 on 07/07/2026
Michael Latimore from Northland Capital Markets set a target price of $18.0 on 03/26/2026

You can track data on $ONDS on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

$MU stock fell 4% this week. Here's what we see in our data.

22 hours ago | Aug. 29, 2026 4:38 p.m. UTC

$MU stock fell 4% this week, according to our price data from Polygon.

It has been the 25th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $MU (you can track the company live on Quiver's $MU stock page):

$MU Insider Trading Activity

$MU insiders have traded $MU stock on the open market 237 times in the past 6 months. Of those trades, 0 have been purchases and 237 have been sales.

Here’s a breakdown of recent trading of $MU stock by insiders over the last 6 months:

SANJAY MEHROTRA (President and CEO) has made 0 purchases and 181 sales selling 200,000 shares for an estimated $182,286,215.
APRIL S ARNZEN (EVP and Chief People Officer) has made 0 purchases and 22 sales selling 80,000 shares for an estimated $57,253,234.
SUMIT SADANA (EVP and Chief Business Officer) has made 0 purchases and 2 sales selling 39,000 shares for an estimated $24,126,750.
MICHAEL CHARLES RAY (SVP, Chief Legal Officer) has made 0 purchases and 25 sales selling 7,601 shares for an estimated $4,061,206.
MICHAEL D CORDANO (EVP, Worldwide Sales) has made 0 purchases and 2 sales selling 6,814 shares for an estimated $2,915,744.
STEVEN J GOMO has made 0 purchases and 2 sales selling 2,000 shares for an estimated $1,574,070.
LYNN A DUGLE sold 1,300 shares for an estimated $1,495,559
SCOTT R. ALLEN (CVP, Chief Accounting Officer) sold 879 shares for an estimated $879,000
ALEXIS BJORLIN sold 25 shares for an estimated $28,308

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$MU Hedge Fund Activity

We have seen 2,279 institutional investors add shares of $MU stock to their portfolio, and 1,607 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JPMORGAN CHASE & CO added 25,836,011 shares (+inf%) to their portfolio in Q2 2026, for an estimated $29,822,249,137
INVESCO LTD. added 24,254,555 shares (+201.1%) to their portfolio in Q2 2026, for an estimated $27,996,790,290
CAPITAL WORLD INVESTORS removed 12,584,746 shares (-29.9%) from their portfolio in Q2 2026, for an estimated $14,526,446,460
PRICE T ROWE ASSOCIATES INC /MD/ added 8,827,282 shares (+165.3%) to their portfolio in Q2 2026, for an estimated $10,189,243,339
NORGES BANK removed 7,360,258 shares (-32.7%) from their portfolio in Q2 2026, for an estimated $8,495,872,206
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 6,966,392 shares (+inf%) to their portfolio in Q2 2026, for an estimated $8,041,236,621
GOLDMAN SACHS GROUP INC added 5,526,936 shares (+44.0%) to their portfolio in Q2 2026, for an estimated $6,379,686,955

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$MU Congressional Stock Trading

Members of Congress have traded $MU stock 10 times in the past 6 months. Of those trades, 7 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $MU stock by members of Congress over the last 6 months:

REPRESENTATIVE DAN NEWHOUSE purchased up to $15,000 on 07/10.
REPRESENTATIVE MICHAEL A. RULLI purchased up to $15,000 on 06/25.
SENATOR SHELDON WHITEHOUSE purchased up to $15,000 on 06/25.
REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 1 purchase worth up to $15,000 on 03/25 and 2 sales worth up to $30,000 on 06/05, 05/15.
REPRESENTATIVE JOSH GOTTHEIMER purchased up to $15,000 on 05/21.
SENATOR JOHN FETTERMAN purchased up to $15,000 on 03/30.
SENATOR ALAN ARMSTRONG purchased up to $50,000 on 03/27.
REPRESENTATIVE DWIGHT EVANS sold up to $50,000 on 03/24.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$MU Price Targets

Multiple analysts have issued price targets for $MU recently. We have seen 25 analysts offer price targets for $MU in the last 6 months, with a median target of $1500.0.

Here are some recent targets:

C.J. Muse from Cantor Fitzgerald set a target price of $2000.0 on 06/29/2026
James Schneider from Goldman Sachs set a target price of $1100.0 on 06/25/2026
Tom O'Malley from Barclays set a target price of $2000.0 on 06/25/2026
Atif Malik from Citigroup set a target price of $1400.0 on 06/25/2026
Vijay Rakesh from Mizuho set a target price of $1375.0 on 06/25/2026
Melissa Weathers from Deutsche Bank set a target price of $1550.0 on 06/25/2026
Matt Bryson from Wedbush set a target price of $1400.0 on 06/25/2026

You can track data on $MU on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

$MRVL stock fell 9% this week. Here's what we see in our data.

22 hours ago | Aug. 29, 2026 4:38 p.m. UTC

$MRVL stock fell 9% this week, according to our price data from Polygon.

It has been the 30th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $MRVL (you can track the company live on Quiver's $MRVL stock page):

$MRVL Insider Trading Activity

$MRVL insiders have traded $MRVL stock on the open market 22 times in the past 6 months. Of those trades, 0 have been purchases and 22 have been sales.

Here’s a breakdown of recent trading of $MRVL stock by insiders over the last 6 months:

SANDEEP BHARATHI (President, Data Center Group) has made 0 purchases and 4 sales selling 122,550 shares for an estimated $15,606,559.
MATTHEW J MURPHY (Chairman of the Board and CEO) has made 0 purchases and 6 sales selling 67,500 shares for an estimated $10,881,600.
CHRIS KOOPMANS (President and COO) has made 0 purchases and 5 sales selling 50,000 shares for an estimated $9,412,900.
WILLEM A MEINTJES (Chief Financial Officer) has made 0 purchases and 2 sales selling 34,000 shares for an estimated $4,721,260.
MARK CASPER (EVP & Chief Legal Officer) has made 0 purchases and 4 sales selling 34,754 shares for an estimated $4,007,461.
DANIEL DURN (Chief Financial Officer) sold 2,250 shares for an estimated $632,272

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$MRVL Hedge Fund Activity

We have seen 1,392 institutional investors add shares of $MRVL stock to their portfolio, and 850 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FMR LLC removed 74,322,607 shares (-56.6%) from their portfolio in Q2 2026, for an estimated $22,139,961,399
BLACKROCK, INC. added 21,798,190 shares (+34.1%) to their portfolio in Q2 2026, for an estimated $6,493,462,819
INVESCO LTD. added 19,762,168 shares (+187.8%) to their portfolio in Q2 2026, for an estimated $5,886,952,225
STATE STREET CORP added 18,495,866 shares (+79.3%) to their portfolio in Q2 2026, for an estimated $5,509,733,522
JPMORGAN CHASE & CO added 13,891,628 shares (+inf%) to their portfolio in Q2 2026, for an estimated $4,138,177,064
PRICE T ROWE ASSOCIATES INC /MD/ added 12,134,409 shares (+714.3%) to their portfolio in Q2 2026, for an estimated $3,614,719,097
AMERIPRISE FINANCIAL INC removed 11,747,911 shares (-56.4%) from their portfolio in Q2 2026, for an estimated $3,499,585,207

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

EARLY ACCESS

Receive MRVL Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$MRVL Congressional Stock Trading

Members of Congress have traded $MRVL stock 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $MRVL stock by members of Congress over the last 6 months:

REPRESENTATIVE MARIA ELVIRA SALAZAR purchased up to $50,000 on 04/06.
REPRESENTATIVE BYRON DONALDS has traded it 2 times. They made 2 purchases worth up to $30,000 on 04/02 and 0 sales.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$MRVL Analyst Ratings

Wall Street analysts have issued reports on $MRVL in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Benchmark issued a "Buy" rating on 03/31/2026

To track analyst ratings and price targets for $MRVL, check out Quiver Quantitative's $MRVL forecast page.

$MRVL Price Targets

Multiple analysts have issued price targets for $MRVL recently. We have seen 25 analysts offer price targets for $MRVL in the last 6 months, with a median target of $250.0.

Here are some recent targets:

Srini Pajjuri from RBC Capital set a target price of $360.0 on 07/07/2026
C.J. Muse from Cantor Fitzgerald set a target price of $300.0 on 06/29/2026
Timothy Arcuri from UBS set a target price of $340.0 on 06/29/2026
Tore Svanberg from Stifel set a target price of $350.0 on 06/24/2026
Vivek Arya from B of A Securities set a target price of $365.0 on 06/23/2026
John Vinh from Keybanc set a target price of $385.0 on 06/18/2026
Craig Ellis from B. Riley Securities set a target price of $345.0 on 06/12/2026

You can track data on $MRVL on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

$APLD stock fell 7% this week. Here's what we see in our data.

22 hours ago | Aug. 29, 2026 4:38 p.m. UTC

$APLD stock fell 7% this week, according to our price data from Polygon.

It has been the 22nd most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $APLD (you can track the company live on Quiver's $APLD stock page):

$APLD Insider Trading Activity

$APLD insiders have traded $APLD stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $APLD stock by insiders over the last 6 months:

RICHARD N NOTTENBURG has made 0 purchases and 3 sales selling 100,000 shares for an estimated $3,168,625.
DOUGLAS S MILLER sold 10,000 shares for an estimated $349,799

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$APLD Hedge Fund Activity

We have seen 333 institutional investors add shares of $APLD stock to their portfolio, and 262 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

TWO SIGMA INVESTMENTS, LP added 8,706,515 shares (+546.7%) to their portfolio in Q2 2026, for an estimated $324,753,009
EQUITEC PROPRIETARY MARKETS, LLC added 8,373,964 shares (+inf%) to their portfolio in Q2 2026, for an estimated $312,348,857
BLACKROCK, INC. removed 7,521,031 shares (-36.0%) from their portfolio in Q2 2026, for an estimated $280,534,456
DBA TRADING, LLC added 5,576,235 shares (+inf%) to their portfolio in Q2 2026, for an estimated $207,993,565
D. E. SHAW & CO., INC. removed 5,172,729 shares (-63.0%) from their portfolio in Q2 2026, for an estimated $192,942,791
OASIS MANAGEMENT CO LTD. added 3,974,500 shares (+384.8%) to their portfolio in Q2 2026, for an estimated $148,248,850
NORGES BANK added 2,783,977 shares (+913.7%) to their portfolio in Q2 2026, for an estimated $103,842,342

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$APLD Price Targets

Multiple analysts have issued price targets for $APLD recently. We have seen 7 analysts offer price targets for $APLD in the last 6 months, with a median target of $79.0.

Here are some recent targets:

Mike Grondahl from Northland Capital Markets set a target price of $82.0 on 06/17/2026
John Todaro from Needham set a target price of $83.0 on 06/09/2026
Rob Brown from Lake Street set a target price of $90.0 on 06/09/2026
George Sutton from Craig-Hallum set a target price of $79.0 on 06/09/2026
Nick Giles from B. Riley Securities set a target price of $66.0 on 05/27/2026
Gregory Miller from Citizens set a target price of $60.0 on 05/21/2026

You can track data on $APLD on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

$TSLA stock fell 4% this week. Here's what we see in our data.

22 hours ago | Aug. 29, 2026 4:38 p.m. UTC

$TSLA stock fell 4% this week, according to our price data from Polygon.

It has been the 36th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $TSLA (you can track the company live on Quiver's $TSLA stock page):

$TSLA Insider Trading Activity

$TSLA insiders have traded $TSLA stock on the open market 34 times in the past 6 months. Of those trades, 0 have been purchases and 34 have been sales.

Here’s a breakdown of recent trading of $TSLA stock by insiders over the last 6 months:

KATHLEEN WILSON-THOMPSON has made 0 purchases and 31 sales selling 52,218 shares for an estimated $19,259,278.
VAIBHAV TANEJA (Chief Financial Officer) has made 0 purchases and 3 sales selling 7,870 shares for an estimated $3,297,000.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$TSLA Hedge Fund Activity

We have seen 2,355 institutional investors add shares of $TSLA stock to their portfolio, and 1,710 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JPMORGAN CHASE & CO added 41,972,287 shares (+inf%) to their portfolio in Q2 2026, for an estimated $17,653,543,912
INVESCO LTD. added 38,527,165 shares (+227.5%) to their portfolio in Q2 2026, for an estimated $16,204,525,599
CORIENT PRIVATE WEALTH LLC removed 20,600,280 shares (-96.0%) from their portfolio in Q1 2026, for an estimated $7,523,119,254
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 19,281,939 shares (+inf%) to their portfolio in Q2 2026, for an estimated $8,109,983,543
SG AMERICAS SECURITIES, LLC added 9,506,960 shares (+559.3%) to their portfolio in Q2 2026, for an estimated $3,998,627,376
BLACKROCK, INC. added 6,028,120 shares (+2.9%) to their portfolio in Q2 2026, for an estimated $2,535,427,272
EXODUSPOINT CAPITAL MANAGEMENT, LP removed 4,915,916 shares (-99.6%) from their portfolio in Q2 2026, for an estimated $2,067,634,269

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$TSLA Congressional Stock Trading

Members of Congress have traded $TSLA stock 5 times in the past 6 months. Of those trades, 4 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $TSLA stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 2 purchases worth up to $30,000 on 05/29, 04/14 and 1 sale worth up to $50,000 on 03/13.
SENATOR ALAN ARMSTRONG has traded it 2 times. They made 2 purchases worth up to $65,000 on 03/30, 03/27 and 0 sales.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$TSLA Analyst Ratings

Wall Street analysts have issued reports on $TSLA in the last several months. We have seen 0 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

GLJ Research issued a "Sell" rating on 03/12/2026

To track analyst ratings and price targets for $TSLA, check out Quiver Quantitative's $TSLA forecast page.

$TSLA Price Targets

Multiple analysts have issued price targets for $TSLA recently. We have seen 14 analysts offer price targets for $TSLA in the last 6 months, with a median target of $462.5.

Here are some recent targets:

Joseph Spak from UBS set a target price of $442.0 on 07/09/2026
Tom Narayan from RBC Capital set a target price of $500.0 on 07/07/2026
William Stein from Truist Securities set a target price of $430.0 on 07/02/2026
Andrew Percoco from Morgan Stanley set a target price of $415.0 on 07/02/2026
Dmitriy Pozdnyakov from Freedom Broker set a target price of $420.0 on 07/02/2026
Gordon L. Johnson from GLJ Research set a target price of $24.86 on 06/12/2026
Rajat Gupta from JP Morgan set a target price of $475.0 on 06/05/2026

You can track data on $TSLA on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

$KEEL stock fell 4% this week. Here's what we see in our data.

22 hours ago | Aug. 29, 2026 4:38 p.m. UTC

$KEEL stock fell 4% this week, according to our price data from Polygon.

It has been the 38th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $KEEL (you can track the company live on Quiver's $KEEL stock page):

$KEEL Insider Trading Activity

$KEEL insiders have traded $KEEL stock on the open market 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $KEEL stock by insiders over the last 6 months:

BENJAMIN GAGNON (Chief Executive Officer) has made 2 purchases buying 97,776 shares for an estimated $325,594 and 0 sales.
LIAM DANIEL WILSON (Chief Operating Officer) has made 2 purchases buying 57,241 shares for an estimated $200,063 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$KEEL Hedge Fund Activity

We have seen 260 institutional investors add shares of $KEEL stock to their portfolio, and 0 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

BLACKROCK, INC. added 43,970,304 shares (+inf%) to their portfolio in Q2 2026, for an estimated $252,389,544
MONARCH ALTERNATIVE CAPITAL LP added 26,285,000 shares (+inf%) to their portfolio in Q2 2026, for an estimated $150,875,900
JANE STREET GROUP, LLC added 23,183,128 shares (+inf%) to their portfolio in Q2 2026, for an estimated $133,071,154
GEODE CAPITAL MANAGEMENT, LLC added 15,604,009 shares (+inf%) to their portfolio in Q2 2026, for an estimated $89,567,011
MORGAN STANLEY added 12,682,283 shares (+inf%) to their portfolio in Q2 2026, for an estimated $72,796,304
INVESCO LTD. added 11,638,359 shares (+inf%) to their portfolio in Q2 2026, for an estimated $66,804,180
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 10,841,676 shares (+inf%) to their portfolio in Q2 2026, for an estimated $62,231,220

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

EARLY ACCESS

Receive KEEL Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$KEEL Price Targets

Multiple analysts have issued price targets for $KEEL recently. We have seen 4 analysts offer price targets for $KEEL in the last 6 months, with a median target of $5.5.

Here are some recent targets:

Greg P. Miller from Citizens set a target price of $10.0 on 06/24/2026
Bill Papanastasiou from Chardan Capital set a target price of $5.5 on 06/08/2026
Mike Colonnese from HC Wainwright & Co. set a target price of $5.5 on 05/11/2026
Brett Knoblauch from Cantor Fitzgerald set a target price of $3.0 on 04/09/2026

You can track data on $KEEL on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

$BSX stock fell 8% this week. Here's what we see in our data.

22 hours ago | Aug. 29, 2026 4:38 p.m. UTC

$BSX stock fell 8% this week, according to our price data from Polygon.

It has been the 37th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $BSX (you can track the company live on Quiver's $BSX stock page):

$BSX Insider Trading Activity

$BSX insiders have traded $BSX stock on the open market 10 times in the past 6 months. Of those trades, 10 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $BSX stock by insiders over the last 6 months:

MICHAEL F MAHONEY (Chairman, President & CEO) purchased 186,240 shares for an estimated $9,001,407
EDWARD J LUDWIG has made 2 purchases buying 8,580 shares for an estimated $430,313 and 0 sales.
DAVID C HABIGER has made 5 purchases buying 7,732 shares for an estimated $407,921 and 0 sales.
SUSAN E MORANO purchased 2,040 shares for an estimated $100,407
CHERYL PEGUS purchased 1,770 shares for an estimated $99,987

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$BSX Hedge Fund Activity

We have seen 730 institutional investors add shares of $BSX stock to their portfolio, and 1,186 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FMR LLC removed 28,523,550 shares (-38.4%) from their portfolio in Q2 2026, for an estimated $1,217,385,114
JPMORGAN CHASE & CO added 23,907,838 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,020,386,525
PRIMECAP MANAGEMENT CO/CA/ added 17,991,140 shares (+55.3%) to their portfolio in Q2 2026, for an estimated $767,861,855
D. E. SHAW & CO., INC. added 14,208,205 shares (+126.3%) to their portfolio in Q2 2026, for an estimated $606,406,189
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ added 13,862,619 shares (+126.1%) to their portfolio in Q2 2026, for an estimated $591,656,578
TWO SIGMA INVESTMENTS, LP added 9,947,792 shares (+105.7%) to their portfolio in Q2 2026, for an estimated $424,571,762
BANK OF AMERICA CORP /DE/ removed 9,728,863 shares (-42.8%) from their portfolio in Q2 2026, for an estimated $415,227,872

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$BSX Government Contracts

We have seen $27,832,520 of award payments to $BSX over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

THERASPHERE Y-90 GLASS MICROSPHERE MEDICATION: $1,260,000
Y90 GLASS MICROSPHERES: $1,227,000
Y90 THERASPHERE: $1,155,000
VAPAHCS THERASPHERE Y90 RADIOPHARMACEUTICALS: $954,240
THERASPHERE YTTIRUM-90 (Y-90) GLASS: $833,910

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

$BSX Congressional Stock Trading

Members of Congress have traded $BSX stock 7 times in the past 6 months. Of those trades, 5 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $BSX stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 5 times. They made 4 purchases worth up to $60,000 on 06/05, 05/29, 05/19, 05/11 and 1 sale worth up to $15,000 on 06/05.
SENATOR JOHN BOOZMAN sold up to $15,000 on 06/04.
SENATOR ALAN ARMSTRONG purchased up to $15,000 on 03/27.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$BSX Analyst Ratings

Wall Street analysts have issued reports on $BSX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

BTIG issued a "Buy" rating on 06/03/2026

To track analyst ratings and price targets for $BSX, check out Quiver Quantitative's $BSX forecast page.

$BSX Price Targets

Multiple analysts have issued price targets for $BSX recently. We have seen 18 analysts offer price targets for $BSX in the last 6 months, with a median target of $70.0.

Here are some recent targets:

Mike Matson from Needham set a target price of $57.0 on 07/08/2026
Vijay Kumar from Evercore ISI Group set a target price of $65.0 on 07/06/2026
Rick Wise from Stifel set a target price of $65.0 on 06/25/2026
Matthew Taylor from Jefferies set a target price of $67.0 on 06/24/2026
Marie Thibault from BTIG set a target price of $65.0 on 06/16/2026
Richard Newitter from Truist Securities set a target price of $64.0 on 06/04/2026
William Plovanic from Canaccord Genuity set a target price of $70.0 on 06/01/2026

You can track data on $BSX on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

$MRNA stock fell 5% this week. Here's what we see in our data.

22 hours ago | Aug. 29, 2026 4:38 p.m. UTC

$MRNA stock fell 5% this week, according to our price data from Polygon.

It has been the 32nd most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $MRNA (you can track the company live on Quiver's $MRNA stock page):

$MRNA Insider Trading Activity

$MRNA insiders have traded $MRNA stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.

Here’s a breakdown of recent trading of $MRNA stock by insiders over the last 6 months:

STEPHANE BANCEL (Chief Executive Officer) has made 0 purchases and 4 sales selling 499,246 shares for an estimated $28,715,011.
STEPHEN HOGE (President) has made 0 purchases and 3 sales selling 160,008 shares for an estimated $8,926,846.
SHANNON THYME KLINGER (Chief Legal Officer) has made 0 purchases and 2 sales selling 17,356 shares for an estimated $899,596.
NOUBAR AFEYAN sold 9,263 shares for an estimated $433,878
ABBAS HUSSAIN sold 5,682 shares for an estimated $264,951

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$MRNA Hedge Fund Activity

We have seen 383 institutional investors add shares of $MRNA stock to their portfolio, and 394 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FMR LLC added 6,187,867 shares (+13.5%) to their portfolio in Q2 2026, for an estimated $433,336,326
D. E. SHAW & CO., INC. removed 5,157,808 shares (-99.5%) from their portfolio in Q2 2026, for an estimated $361,201,294
PRICE T ROWE ASSOCIATES INC /MD/ added 4,850,982 shares (+656.8%) to their portfolio in Q2 2026, for an estimated $339,714,269
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 4,838,884 shares (+inf%) to their portfolio in Q2 2026, for an estimated $338,867,046
CAPITAL WORLD INVESTORS added 3,579,302 shares (+19.1%) to their portfolio in Q2 2026, for an estimated $250,658,519
ALYESKA INVESTMENT GROUP, L.P. removed 3,490,366 shares (-86.2%) from their portfolio in Q2 2026, for an estimated $244,430,330
BAILLIE GIFFORD & CO removed 2,373,736 shares (-11.5%) from their portfolio in Q2 2026, for an estimated $166,232,732

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

EARLY ACCESS

Receive MRNA Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$MRNA Price Targets

Multiple analysts have issued price targets for $MRNA recently. We have seen 8 analysts offer price targets for $MRNA in the last 6 months, with a median target of $46.5.

Here are some recent targets:

Matthew Harrison from Morgan Stanley set a target price of $39.0 on 07/08/2026
Luca Issi from RBC Capital set a target price of $45.0 on 07/07/2026
Dimple Gosai from B of A Securities set a target price of $38.0 on 07/07/2026
Edward Tenthoff from Piper Sandler set a target price of $77.0 on 06/26/2026
Salveen Richter from Goldman Sachs set a target price of $49.0 on 05/04/2026
Cory Kasimov from Evercore ISI Group set a target price of $50.0 on 05/04/2026
Eliana Merle from UBS set a target price of $45.0 on 05/04/2026

You can track data on $MRNA on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

$INFQ stock fell 10% this week. Here's what we see in our data.

22 hours ago | Aug. 29, 2026 4:38 p.m. UTC

$INFQ stock fell 10% this week, according to our price data from Polygon.

It has been the 29th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $INFQ (you can track the company live on Quiver's $INFQ stock page):

$INFQ Insider Trading Activity

$INFQ insiders have traded $INFQ stock on the open market 60 times in the past 6 months. Of those trades, 1 have been purchases and 59 have been sales.

Here’s a breakdown of recent trading of $INFQ stock by insiders over the last 6 months:

CAPITAL LTD MAVERICK has made 1 purchase buying 52,071 shares for an estimated $646,836 and 32 sales selling 13,955,567 shares for an estimated $218,111,292.
DAVID B SINGER has made 0 purchases and 18 sales selling 13,416,767 shares for an estimated $210,534,930.
MATTHEW JOHN KINSELLA (Chief Executive Officer) has made 0 purchases and 5 sales selling 769,954 shares for an estimated $13,115,941.
PRANAV GOKHALE (Chief Technology Officer) sold 120,000 shares for an estimated $2,127,600
PAUL LIPMAN (Chief Revenue Officer) sold 100,000 shares for an estimated $1,583,000
KRISTINA M JOHNSON has made 0 purchases and 2 sales selling 50,000 shares for an estimated $853,500.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$INFQ Hedge Fund Activity

We have seen 222 institutional investors add shares of $INFQ stock to their portfolio, and 38 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

MAVERICK CAPITAL LTD removed 19,941,924 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $265,626,427
S&G FOUNDATION added 11,573,878 shares (+inf%) to their portfolio in Q2 2026, for an estimated $154,164,054
BLACKROCK, INC. added 9,034,636 shares (+inf%) to their portfolio in Q2 2026, for an estimated $120,341,351
DEFIANCE ETFS, LLC added 4,937,608 shares (+inf%) to their portfolio in Q2 2026, for an estimated $65,768,938
PENSERRA CAPITAL MANAGEMENT LLC added 4,897,881 shares (+inf%) to their portfolio in Q2 2026, for an estimated $65,239,774
ALYESKA INVESTMENT GROUP, L.P. removed 4,535,369 shares (-90.7%) from their portfolio in Q2 2026, for an estimated $60,411,115
GLYNN CAPITAL MANAGEMENT LLC added 4,315,260 shares (+inf%) to their portfolio in Q2 2026, for an estimated $57,479,263

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

EARLY ACCESS

Receive INFQ Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$INFQ Price Targets

Multiple analysts have issued price targets for $INFQ recently. We have seen 3 analysts offer price targets for $INFQ in the last 6 months, with a median target of $20.0.

Here are some recent targets:

Kingsley Crane from Canaccord Genuity set a target price of $22.0 on 07/02/2026
Antoine Legault from Wedbush set a target price of $20.0 on 06/26/2026
Atif Malik from Citigroup set a target price of $20.0 on 04/14/2026

You can track data on $INFQ on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

$NOW stock rose 12% this week. Here's what we see in our data.

22 hours ago | Aug. 29, 2026 4:37 p.m. UTC

$NOW stock rose 12% this week, according to our price data from Polygon.

It has been the 26th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $NOW (you can track the company live on Quiver's $NOW stock page):

$NOW Insider Trading Activity

$NOW insiders have traded $NOW stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $NOW stock by insiders over the last 6 months:

ANITA M SANDS sold 16,445 shares for an estimated $1,482,401
JACQUELINE P CANNEY (Chief People & AI Enblmt. Off.) sold 8,927 shares for an estimated $799,868
PAUL EDWARD CHAMBERLAIN has made 0 purchases and 2 sales selling 3,000 shares for an estimated $319,245.
TERESA BRIGGS sold 1,595 shares for an estimated $173,376
PAUL FIPPS (President, Global Customer Ops) sold 1,048 shares for an estimated $103,238

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$NOW Hedge Fund Activity

We have seen 1,284 institutional investors add shares of $NOW stock to their portfolio, and 1,341 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

PRICE T ROWE ASSOCIATES INC /MD/ removed 18,043,553 shares (-52.9%) from their portfolio in Q2 2026, for an estimated $1,791,363,941
JPMORGAN CHASE & CO added 13,949,279 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,384,884,419
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 8,080,617 shares (+inf%) to their portfolio in Q2 2026, for an estimated $802,243,655
SG AMERICAS SECURITIES, LLC added 5,062,556 shares (+744.8%) to their portfolio in Q2 2026, for an estimated $502,610,559
WELLINGTON MANAGEMENT GROUP LLP removed 4,905,136 shares (-89.3%) from their portfolio in Q2 2026, for an estimated $486,981,902
TWO SIGMA INVESTMENTS, LP removed 4,533,997 shares (-97.8%) from their portfolio in Q2 2026, for an estimated $450,135,222
AMUNDI added 4,346,722 shares (+60.9%) to their portfolio in Q1 2026, for an estimated $455,275,662

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$NOW Government Contracts

We have seen $749,146 of award payments to $NOW over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

SOFTWARE LICENSE RENEWAL: $749,146

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

$NOW Congressional Stock Trading

Members of Congress have traded $NOW stock 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $NOW stock by members of Congress over the last 6 months:

REPRESENTATIVE JOSH GOTTHEIMER has traded it 2 times. They made 1 purchase worth up to $15,000 on 03/06 and 1 sale worth up to $15,000 on 04/24.
REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 04/14.
SENATOR ALAN ARMSTRONG sold up to $50,000 on 03/27.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$NOW Price Targets

Multiple analysts have issued price targets for $NOW recently. We have seen 29 analysts offer price targets for $NOW in the last 6 months, with a median target of $134.0.

Here are some recent targets:

Miller Jump from Truist Securities set a target price of $130.0 on 07/09/2026
Kash Rangan from Goldman Sachs set a target price of $145.0 on 07/09/2026
John Difucci from Guggenheim set a target price of $125.0 on 07/01/2026
Allan Verkhovski from BTIG set a target price of $150.0 on 06/29/2026
Yi Fu Lee from Benchmark set a target price of $130.0 on 06/15/2026
Tal Liani from B of A Securities set a target price of $130.0 on 05/18/2026
Peter Weed from Bernstein set a target price of $236.0 on 05/06/2026

You can track data on $NOW on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

$META stock rose 5% this week. Here's what we see in our data.

22 hours ago | Aug. 29, 2026 4:37 p.m. UTC

$META stock rose 5% this week, according to our price data from Polygon.

It has been the 33rd most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $META (you can track the company live on Quiver's $META stock page):

$META Insider Trading Activity

$META insiders have traded $META stock on the open market 158 times in the past 6 months. Of those trades, 0 have been purchases and 158 have been sales.

Here’s a breakdown of recent trading of $META stock by insiders over the last 6 months:

JAVIER OLIVAN (Chief Operating Officer) has made 0 purchases and 114 sales selling 34,923 shares for an estimated $21,801,664.
SUSAN J LI (Chief Financial Officer) has made 0 purchases and 22 sales selling 22,645 shares for an estimated $13,435,233.
ANDREW BOSWORTH (Chief Technology Officer) has made 0 purchases and 9 sales selling 15,695 shares for an estimated $9,148,826.
CURTIS J. MAHONEY (Chief Legal Officer) has made 0 purchases and 2 sales selling 3,638 shares for an estimated $2,137,945.
ROBERT M KIMMITT has made 0 purchases and 5 sales selling 2,664 shares for an estimated $1,655,248.
PEGGY ALFORD has made 0 purchases and 2 sales selling 873 shares for an estimated $503,554.
MARC L ANDREESSEN has made 0 purchases and 4 sales selling 426 shares for an estimated $250,907.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$META Hedge Fund Activity

We have seen 2,663 institutional investors add shares of $META stock to their portfolio, and 2,284 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JPMORGAN CHASE & CO added 45,944,387 shares (+inf%) to their portfolio in Q2 2026, for an estimated $25,880,013,753
INVESCO LTD. added 22,767,345 shares (+145.9%) to their portfolio in Q2 2026, for an estimated $12,824,617,765
FMR LLC removed 20,719,009 shares (-17.8%) from their portfolio in Q2 2026, for an estimated $11,670,810,579
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 15,438,261 shares (+inf%) to their portfolio in Q2 2026, for an estimated $8,696,218,038
CAPITAL RESEARCH GLOBAL INVESTORS added 8,709,803 shares (+28.2%) to their portfolio in Q2 2026, for an estimated $4,906,144,931
BLACKROCK, INC. added 4,553,693 shares (+2.7%) to their portfolio in Q2 2026, for an estimated $2,565,049,729
WELLINGTON MANAGEMENT GROUP LLP removed 4,464,151 shares (-38.2%) from their portfolio in Q2 2026, for an estimated $2,514,611,616

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

EARLY ACCESS

Receive META Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$META Congressional Stock Trading

Members of Congress have traded $META stock 7 times in the past 6 months. Of those trades, 5 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $META stock by members of Congress over the last 6 months:

REPRESENTATIVE JARED MOSKOWITZ has traded it 2 times. They made 2 purchases worth up to $30,000 on 06/17 and 0 sales.
REPRESENTATIVE MATTHEW VAN EPPS sold up to $15,000 on 06/16.
REPRESENTATIVE JOHN MCGUIRE purchased up to $15,000 on 06/04.
REPRESENTATIVE DAN CRENSHAW sold up to $15,000 on 06/01.
REPRESENTATIVE MICHAEL A. RULLI purchased up to $15,000 on 05/06.
SENATOR ALAN ARMSTRONG purchased up to $50,000 on 03/27.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$META Analyst Ratings

Wall Street analysts have issued reports on $META in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Erste Group issued a "Buy" rating on 07/07/2026
Guggenheim issued a "Buy" rating on 04/30/2026
Barclays issued a "Overweight" rating on 04/30/2026
Evercore ISI Group issued a "Outperform" rating on 04/30/2026
Wells Fargo issued a "Overweight" rating on 04/30/2026

To track analyst ratings and price targets for $META, check out Quiver Quantitative's $META forecast page.

$META Price Targets

Multiple analysts have issued price targets for $META recently. We have seen 20 analysts offer price targets for $META in the last 6 months, with a median target of $815.0.

Here are some recent targets:

Ken Gawrelski from Wells Fargo set a target price of $767.0 on 07/02/2026
Brad Erickson from RBC Capital set a target price of $810.0 on 06/01/2026
Barton Crockett from Rosenblatt set a target price of $1015.0 on 05/28/2026
Lloyd Walmsley from Mizuho set a target price of $835.0 on 05/05/2026
Mark Kelley from Stifel set a target price of $780.0 on 05/01/2026
Stephen Ju from UBS set a target price of $865.0 on 04/30/2026
Doug Anmuth from JP Morgan set a target price of $725.0 on 04/30/2026

You can track data on $META on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

$APP stock rose 3% this week. Here's what we see in our data.

22 hours ago | Aug. 29, 2026 4:37 p.m. UTC

$APP stock rose 3% this week, according to our price data from Polygon.

It has been the 35th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $APP (you can track the company live on Quiver's $APP stock page):

$APP Insider Trading Activity

$APP insiders have traded $APP stock on the open market 400 times in the past 6 months. Of those trades, 0 have been purchases and 400 have been sales.

Here’s a breakdown of recent trading of $APP stock by insiders over the last 6 months:

EDUARDO VIVAS has made 0 purchases and 48 sales selling 348,730 shares for an estimated $166,542,804.
ARASH ADAM FOROUGHI (CEO) has made 0 purchases and 113 sales selling 204,166 shares for an estimated $97,285,375.
VASILY SHIKIN (Chief Technology Officer) has made 0 purchases and 190 sales selling 179,440 shares for an estimated $87,104,324.
VICTORIA VALENZUELA (CALO & Corp. Secretary) has made 0 purchases and 29 sales selling 20,000 shares for an estimated $11,317,855.
MATTHEW STUMPF (Chief Financial Officer (CFO)) sold 9,052 shares for an estimated $5,431,200
MAYNARD G JR WEBB has made 0 purchases and 17 sales selling 6,152 shares for an estimated $3,393,853.
DMITRIY DOROSH (Principal Accounting Officer) has made 0 purchases and 2 sales selling 3,109 shares for an estimated $1,409,678.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$APP Hedge Fund Activity

We have seen 803 institutional investors add shares of $APP stock to their portfolio, and 891 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

INVESCO LTD. added 6,831,277 shares (+164.8%) to their portfolio in Q2 2026, for an estimated $3,519,678,848
CAPITAL WORLD INVESTORS added 4,971,394 shares (+156.4%) to their portfolio in Q2 2026, for an estimated $2,561,411,330
JPMORGAN CHASE & CO added 4,349,233 shares (+inf%) to their portfolio in Q2 2026, for an estimated $2,240,855,318
CORIENT PRIVATE WEALTH LLC removed 4,056,153 shares (-96.7%) from their portfolio in Q1 2026, for an estimated $1,614,348,894
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 2,104,222 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,084,158,301
FMR LLC added 1,602,139 shares (+10.2%) to their portfolio in Q2 2026, for an estimated $825,470,076
TIGER GLOBAL MANAGEMENT LLC removed 1,292,984 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $666,184,146

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

EARLY ACCESS

Receive APP Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$APP Congressional Stock Trading

Members of Congress have traded $APP stock 5 times in the past 6 months. Of those trades, 3 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $APP stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 4 times. They made 2 purchases worth up to $30,000 on 05/15, 03/13 and 2 sales worth up to $65,000 on 04/14, 03/18.
SENATOR ALAN ARMSTRONG purchased up to $15,000 on 03/27.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$APP Price Targets

Multiple analysts have issued price targets for $APP recently. We have seen 12 analysts offer price targets for $APP in the last 6 months, with a median target of $650.0.

Here are some recent targets:

Alec Brondolo from Wells Fargo set a target price of $575.0 on 07/07/2026
Andrew Marok from Raymond James set a target price of $640.0 on 06/29/2026
Jason Bazinet from Citigroup set a target price of $710.0 on 06/01/2026
Bernie McTernan from Needham set a target price of $700.0 on 05/28/2026
John Hodulik from UBS set a target price of $750.0 on 05/07/2026
Aaron Lee from Macquarie set a target price of $730.0 on 05/07/2026
Cory Carpenter from JP Morgan set a target price of $515.0 on 05/07/2026

You can track data on $APP on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

$AMZN stock rose 3% this week. Here's what we see in our data.

22 hours ago | Aug. 29, 2026 4:37 p.m. UTC

$AMZN stock rose 3% this week, according to our price data from Polygon.

It has been the 21st most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $AMZN (you can track the company live on Quiver's $AMZN stock page):

$AMZN Insider Trading Activity

$AMZN insiders have traded $AMZN stock on the open market 64 times in the past 6 months. Of those trades, 0 have been purchases and 64 have been sales.

Here’s a breakdown of recent trading of $AMZN stock by insiders over the last 6 months:

JEFFREY P BEZOS (Executive Chair) sold 1,209,649 shares for an estimated $346,453,513
ANDREW R JASSY (President and CEO) has made 0 purchases and 11 sales selling 102,352 shares for an estimated $26,975,355.
DOUGLAS J HERRINGTON (CEO Worldwide Amazon Stores) has made 0 purchases and 20 sales selling 74,215 shares for an estimated $19,334,594.
MATTHEW S GARMAN (CEO Amazon Web Services) has made 0 purchases and 12 sales selling 41,483 shares for an estimated $10,854,849.
DAVID ZAPOLSKY (Senior Vice President) has made 0 purchases and 11 sales selling 30,880 shares for an estimated $8,121,596.
JONATHAN RUBINSTEIN has made 0 purchases and 2 sales selling 7,555 shares for an estimated $2,012,552.
BRIAN T OLSAVSKY (Senior Vice President and CFO) sold 6,172 shares for an estimated $1,606,633
SHELLEY REYNOLDS (Vice President) has made 0 purchases and 6 sales selling 4,706 shares for an estimated $1,226,857.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$AMZN Hedge Fund Activity

We have seen 3,222 institutional investors add shares of $AMZN stock to their portfolio, and 2,630 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JPMORGAN CHASE & CO added 167,979,147 shares (+inf%) to their portfolio in Q2 2026, for an estimated $40,036,149,895
INVESCO LTD. added 86,675,127 shares (+151.7%) to their portfolio in Q2 2026, for an estimated $20,658,149,769
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 66,029,318 shares (+inf%) to their portfolio in Q2 2026, for an estimated $15,737,427,652
SG AMERICAS SECURITIES, LLC added 22,210,798 shares (+367.5%) to their portfolio in Q2 2026, for an estimated $5,293,721,595
ALLIANCEBERNSTEIN L.P. removed 14,917,149 shares (-28.3%) from their portfolio in Q2 2026, for an estimated $3,555,353,292
PRICE T ROWE ASSOCIATES INC /MD/ removed 14,091,485 shares (-11.5%) from their portfolio in Q2 2026, for an estimated $3,358,564,534
BLACKROCK, INC. added 12,838,547 shares (+1.7%) to their portfolio in Q2 2026, for an estimated $3,059,939,291

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$AMZN Congressional Stock Trading

Members of Congress have traded $AMZN stock 14 times in the past 6 months. Of those trades, 6 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $AMZN stock by members of Congress over the last 6 months:

REPRESENTATIVE THOMAS H. KEAN, JR. purchased up to $15,000 on 07/08.
REPRESENTATIVE MICHAEL A. RULLI sold up to $15,000 on 06/25.
REPRESENTATIVE MATTHEW VAN EPPS sold up to $15,000 on 06/16.
REPRESENTATIVE DAVID TAYLOR sold up to $15,000 on 06/05.
REPRESENTATIVE DAN CRENSHAW sold up to $15,000 on 06/01.
REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 5 times. They made 3 purchases worth up to $45,000 on 04/22, 04/14, 03/16 and 2 sales worth up to $30,000 on 03/16, 03/13.
SENATOR JOHN FETTERMAN purchased up to $15,000 on 03/30.
SENATOR ALAN ARMSTRONG purchased up to $50,000 on 03/27.
REPRESENTATIVE MARK ALFORD sold up to $15,000 on 03/16.
REPRESENTATIVE JONATHAN L. JACKSON sold up to $15,000 on 03/09.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$AMZN Analyst Ratings

Wall Street analysts have issued reports on $AMZN in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

RBC Capital issued a "Outperform" rating on 04/30/2026
Piper Sandler issued a "Overweight" rating on 04/30/2026
Guggenheim issued a "Buy" rating on 04/30/2026
Barclays issued a "Overweight" rating on 04/30/2026
Benchmark issued a "Buy" rating on 04/30/2026
Evercore ISI Group issued a "Outperform" rating on 04/30/2026
Wells Fargo issued a "Overweight" rating on 04/30/2026

To track analyst ratings and price targets for $AMZN, check out Quiver Quantitative's $AMZN forecast page.

$AMZN Price Targets

Multiple analysts have issued price targets for $AMZN recently. We have seen 29 analysts offer price targets for $AMZN in the last 6 months, with a median target of $320.0.

Here are some recent targets:

John Blackledge from TD Cowen set a target price of $340.0 on 07/08/2026
Ken Gawrelski from Wells Fargo set a target price of $313.0 on 07/02/2026
Youssef Squali from Truist Securities set a target price of $320.0 on 05/29/2026
Mark Kelley from Stifel set a target price of $319.0 on 05/01/2026
Daniel L. Kurnos from Benchmark set a target price of $370.0 on 04/30/2026
Maria Ripps from Canaccord Genuity set a target price of $330.0 on 04/30/2026
Joseph Feldman from Telsey Advisory Group set a target price of $315.0 on 04/30/2026

You can track data on $AMZN on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

$CRWD stock rose 13% this week. Here's what we see in our data.

22 hours ago | Aug. 29, 2026 4:37 p.m. UTC

$CRWD stock rose 13% this week, according to our price data from Polygon.

It has been the 40th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $CRWD (you can track the company live on Quiver's $CRWD stock page):

$CRWD Insider Trading Activity

$CRWD insiders have traded $CRWD stock on the open market 1480 times in the past 6 months. Of those trades, 0 have been purchases and 1480 have been sales.

Here’s a breakdown of recent trading of $CRWD stock by insiders over the last 6 months:

GEORGE KURTZ (PRESIDENT AND CEO) has made 0 purchases and 1339 sales selling 591,579 shares for an estimated $185,389,829.
SAMEER K GANDHI has made 0 purchases and 104 sales selling 57,183 shares for an estimated $28,619,901.
MICHAEL SENTONAS (PRESIDENT) has made 0 purchases and 3 sales selling 41,583 shares for an estimated $21,827,248.
BURT W. PODBERE (CHIEF FINANCIAL OFFICER) has made 0 purchases and 26 sales selling 33,871 shares for an estimated $14,710,383.
GERHARD WATZINGER has made 0 purchases and 2 sales selling 10,000 shares for an estimated $6,963,100.
ANURAG SAHA (CHIEF ACCOUNTING OFFICER) has made 0 purchases and 4 sales selling 7,513 shares for an estimated $4,018,782.
DENIS OLEARY sold 14,500 shares for an estimated $2,724,115
JOHANNA FLOWER sold 402 shares for an estimated $0

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$CRWD Hedge Fund Activity

We have seen 1,361 institutional investors add shares of $CRWD stock to their portfolio, and 1,109 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JPMORGAN CHASE & CO added 32,697,852 shares (+inf%) to their portfolio in Q2 2026, for an estimated $6,238,259,693
FMR LLC added 17,627,660 shares (+128.1%) to their portfolio in Q2 2026, for an estimated $3,363,093,113
NORGES BANK added 14,679,044 shares (+inf%) to their portfolio in Q2 2026, for an estimated $2,800,541,409
PRICE T ROWE ASSOCIATES INC /MD/ removed 12,300,773 shares (-74.1%) from their portfolio in Q2 2026, for an estimated $2,346,802,976
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 7,972,808 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,521,092,174
BANK OF AMERICA CORP /DE/ removed 7,068,281 shares (-74.3%) from their portfolio in Q2 2026, for an estimated $1,348,521,990
LEGAL & GENERAL GROUP PLC removed 5,958,481 shares (-76.4%) from their portfolio in Q2 2026, for an estimated $1,136,788,797

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

EARLY ACCESS

Receive CRWD Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$CRWD Congressional Stock Trading

Members of Congress have traded $CRWD stock 5 times in the past 6 months. Of those trades, 3 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $CRWD stock by members of Congress over the last 6 months:

REPRESENTATIVE JOSH GOTTHEIMER purchased up to $15,000 on 07/15.
REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 2 purchases worth up to $30,000 on 05/15, 03/13 and 1 sale worth up to $15,000 on 04/14.
SENATOR ALAN ARMSTRONG sold up to $50,000 on 03/27.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$CRWD Analyst Ratings

Wall Street analysts have issued reports on $CRWD in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Stifel issued a "Buy" rating on 07/07/2026
UBS issued a "Buy" rating on 06/04/2026
Citigroup issued a "Buy" rating on 06/04/2026

To track analyst ratings and price targets for $CRWD, check out Quiver Quantitative's $CRWD forecast page.

$CRWD Price Targets

Multiple analysts have issued price targets for $CRWD recently. We have seen 35 analysts offer price targets for $CRWD in the last 6 months, with a median target of $710.0.

Here are some recent targets:

Mike Cikos from Needham set a target price of $235.0 on 07/09/2026
Yi Fu Lee from Benchmark set a target price of $230.0 on 07/08/2026
Roger Boyd from UBS set a target price of $235.0 on 07/07/2026
Adam Borg from Stifel set a target price of $220.0 on 07/07/2026
Keith Weiss from Morgan Stanley set a target price of $172.0 on 07/07/2026
Saket Kalia from Barclays set a target price of $169.0 on 07/06/2026
Catharine Trebnick from Rosenblatt set a target price of $825.0 on 06/23/2026

You can track data on $CRWD on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

$ELF stock rose 2% this week. Here's what we see in our data.

22 hours ago | Aug. 29, 2026 4:37 p.m. UTC

$ELF stock rose 2% this week, according to our price data from Polygon.

It has been the 24th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $ELF (you can track the company live on Quiver's $ELF stock page):

$ELF Insider Trading Activity

$ELF insiders have traded $ELF stock on the open market 28 times in the past 6 months. Of those trades, 0 have been purchases and 28 have been sales.

Here’s a breakdown of recent trading of $ELF stock by insiders over the last 6 months:

TARANG AMIN (Chief Executive Officer) has made 0 purchases and 8 sales selling 91,684 shares for an estimated $6,568,015.
JENNIFER CATHERINE HARTNETT (Chief Commercial Officer) has made 0 purchases and 4 sales selling 60,856 shares for an estimated $4,114,709.
KORY MARCHISOTTO (See Remarks) has made 0 purchases and 4 sales selling 48,833 shares for an estimated $3,252,640.
JOSHUA ALLEN FRANKS (SVP, Operations) has made 0 purchases and 4 sales selling 39,612 shares for an estimated $2,606,647.
SCOTT MILSTEN has made 0 purchases and 3 sales selling 36,471 shares for an estimated $2,171,498.
MANDY J FIELDS (See Remarks) has made 0 purchases and 3 sales selling 36,447 shares for an estimated $2,168,531.
LAUREN COOKS LEVITAN has made 0 purchases and 2 sales selling 8,748 shares for an estimated $530,697.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$ELF Hedge Fund Activity

We have seen 214 institutional investors add shares of $ELF stock to their portfolio, and 312 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

PRICE T ROWE ASSOCIATES INC /MD/ removed 1,981,336 shares (-95.8%) from their portfolio in Q2 2026, for an estimated $146,618,864
JPMORGAN CHASE & CO added 1,960,653 shares (+inf%) to their portfolio in Q2 2026, for an estimated $145,088,322
CLEARBRIDGE INVESTMENTS, LLC removed 1,529,086 shares (-88.1%) from their portfolio in Q2 2026, for an estimated $113,152,364
AQR CAPITAL MANAGEMENT LLC removed 1,473,881 shares (-98.5%) from their portfolio in Q2 2026, for an estimated $109,067,194
HOLOCENE ADVISORS, LP added 1,356,999 shares (+inf%) to their portfolio in Q2 2026, for an estimated $100,417,926
ILEX CAPITAL PARTNERS (UK) LLP removed 1,257,126 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $76,194,406
GOLDMAN SACHS GROUP INC added 1,222,786 shares (+175.0%) to their portfolio in Q2 2026, for an estimated $90,486,164

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$ELF Price Targets

Multiple analysts have issued price targets for $ELF recently. We have seen 13 analysts offer price targets for $ELF in the last 6 months, with a median target of $70.0.

Here are some recent targets:

Cristian Rios from Bernstein set a target price of $60.0 on 06/11/2026
Anna Glaessgen from B. Riley Securities set a target price of $70.0 on 05/26/2026
Anna Lizzul from B of A Securities set a target price of $85.0 on 05/21/2026
Susan Anderson from Canaccord Genuity set a target price of $90.0 on 05/21/2026
Dara Mohsenian from Morgan Stanley set a target price of $59.0 on 05/21/2026
Anna Andreeva from Piper Sandler set a target price of $50.0 on 05/21/2026
Ashley Helgans from Jefferies set a target price of $70.0 on 05/21/2026

You can track data on $ELF on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

$PANW stock rose 3% this week. Here's what we see in our data.

22 hours ago | Aug. 29, 2026 4:37 p.m. UTC

$PANW stock rose 3% this week, according to our price data from Polygon.

It has been the 49th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $PANW (you can track the company live on Quiver's $PANW stock page):

$PANW Insider Trading Activity

$PANW insiders have traded $PANW stock on the open market 31 times in the past 6 months. Of those trades, 2 have been purchases and 29 have been sales.

Here’s a breakdown of recent trading of $PANW stock by insiders over the last 6 months:

NIKESH ARORA (Chief Executive Officer) has made 2 purchases buying 68,085 shares for an estimated $9,999,976 and 0 sales.
JAMES J GOETZ has made 0 purchases and 7 sales selling 42,684 shares for an estimated $9,327,421.
JOHN P. KEY has made 0 purchases and 2 sales selling 9,072 shares for an estimated $2,366,759.
DIPAK GOLECHHA (EVP, Chief Financial Officer) has made 0 purchases and 9 sales selling 10,000 shares for an estimated $2,249,901.
JOSH D. PAUL (Chief Accounting Officer) has made 0 purchases and 3 sales selling 2,900 shares for an estimated $806,433.
APARNA BAWA has made 0 purchases and 7 sales selling 2,735 shares for an estimated $802,475.
HELLE THORNING-SCHMIDT sold 700 shares for an estimated $242,795

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$PANW Hedge Fund Activity

We have seen 1,554 institutional investors add shares of $PANW stock to their portfolio, and 1,388 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JPMORGAN CHASE & CO added 21,715,578 shares (+inf%) to their portfolio in Q2 2026, for an estimated $7,405,446,409
INVESCO LTD. added 18,845,481 shares (+277.0%) to their portfolio in Q2 2026, for an estimated $6,426,685,930
FMR LLC added 11,949,672 shares (+147.4%) to their portfolio in Q2 2026, for an estimated $4,075,077,145
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 6,382,853 shares (+inf%) to their portfolio in Q2 2026, for an estimated $2,176,680,530
FISHER ASSET MANAGEMENT, LLC added 5,499,328 shares (+2142.6%) to their portfolio in Q2 2026, for an estimated $1,875,380,834
BLACKROCK, INC. added 3,322,076 shares (+4.6%) to their portfolio in Q2 2026, for an estimated $1,132,894,357
MORGAN STANLEY removed 2,868,846 shares (-8.9%) from their portfolio in Q2 2026, for an estimated $978,333,862

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$PANW Congressional Stock Trading

Members of Congress have traded $PANW stock 10 times in the past 6 months. Of those trades, 8 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $PANW stock by members of Congress over the last 6 months:

REPRESENTATIVE JOHN MCGUIRE sold up to $15,000 on 07/31.
REPRESENTATIVE JOSH GOTTHEIMER has traded it 2 times. They made 2 purchases worth up to $30,000 on 07/16, 05/14 and 0 sales.
REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 07/10.
REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 2 purchases worth up to $30,000 on 04/14, 03/13 and 0 sales.
REPRESENTATIVE JARED MOSKOWITZ has traded it 3 times. They made 3 purchases worth up to $45,000 on 03/31, 03/23 and 0 sales.
SENATOR ALAN ARMSTRONG purchased up to $15,000 on 03/27.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$PANW Analyst Ratings

Wall Street analysts have issued reports on $PANW in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

BTIG issued a "Buy" rating on 06/30/2026
Citigroup issued a "Buy" rating on 06/03/2026

To track analyst ratings and price targets for $PANW, check out Quiver Quantitative's $PANW forecast page.

$PANW Price Targets

Multiple analysts have issued price targets for $PANW recently. We have seen 31 analysts offer price targets for $PANW in the last 6 months, with a median target of $330.0.

Here are some recent targets:

Peter Levine from Evercore ISI Group set a target price of $320.0 on 07/08/2026
Mike Cikos from Needham set a target price of $425.0 on 07/07/2026
Michael Turrin from Wells Fargo set a target price of $420.0 on 07/01/2026
Gray Powell from BTIG set a target price of $380.0 on 06/30/2026
Junaid Siddiqui from Truist Securities set a target price of $375.0 on 06/03/2026
Matthew Hedberg from RBC Capital set a target price of $330.0 on 06/03/2026
Joseph Gallo from Jefferies set a target price of $335.0 on 06/03/2026

You can track data on $PANW on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article

$CRM stock rose 22% this week. Here's what we see in our data.

22 hours ago | Aug. 29, 2026 4:37 p.m. UTC

$CRM stock rose 22% this week, according to our price data from Polygon.

It has been the 39th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $CRM (you can track the company live on Quiver's $CRM stock page):

$CRM Insider Trading Activity

$CRM insiders have traded $CRM stock on the open market 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $CRM stock by insiders over the last 6 months:

LAURA ALBER has made 2 purchases buying 2,571 shares for an estimated $500,266 and 0 sales.
DAVID BLAIR KIRK purchased 2,570 shares for an estimated $500,178

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$CRM Hedge Fund Activity

We have seen 1,018 institutional investors add shares of $CRM stock to their portfolio, and 2,031 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JPMORGAN CHASE & CO added 10,440,961 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,635,680,950
MORGAN STANLEY removed 8,364,287 shares (-26.4%) from their portfolio in Q2 2026, for an estimated $1,310,349,201
CAPITAL WORLD INVESTORS removed 8,024,160 shares (-48.0%) from their portfolio in Q2 2026, for an estimated $1,257,064,905
BLACKROCK, INC. removed 6,942,275 shares (-8.7%) from their portfolio in Q2 2026, for an estimated $1,087,576,801
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 6,600,642 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,034,056,575
ALYESKA INVESTMENT GROUP, L.P. added 4,662,005 shares (+inf%) to their portfolio in Q2 2026, for an estimated $730,349,703
CAPITAL INTERNATIONAL INVESTORS removed 4,472,425 shares (-35.4%) from their portfolio in Q2 2026, for an estimated $700,650,100

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$CRM Congressional Stock Trading

Members of Congress have traded $CRM stock 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $CRM stock by members of Congress over the last 6 months:

REPRESENTATIVE MARIA ELVIRA SALAZAR has traded it 2 times. They made 2 purchases worth up to $100,000 on 06/02, 04/06 and 0 sales.
SENATOR ALAN ARMSTRONG purchased up to $15,000 on 03/27.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$CRM Price Targets

Multiple analysts have issued price targets for $CRM recently. We have seen 21 analysts offer price targets for $CRM in the last 6 months, with a median target of $228.0.

Here are some recent targets:

John Difucci from Guggenheim set a target price of $228.0 on 07/01/2026
David Hynes from Canaccord Genuity set a target price of $225.0 on 06/16/2026
Scott Berg from Needham set a target price of $400.0 on 06/16/2026
Derrick Wood from TD Cowen set a target price of $240.0 on 05/28/2026
Tyler Radke from Citigroup set a target price of $187.0 on 05/28/2026
Mark Moerdler from Bernstein set a target price of $173.0 on 05/28/2026
Patrick Walravens from Citizens set a target price of $315.0 on 05/28/2026

You can track data on $CRM on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read Full Article